Archives: CannabisNewsWire

A survey conducted by Gallup has found that the majority of Americans who are familiar with CBD (cannabidiol) want it available as an over-the-counter drug. The results of the survey were released on Friday last week (June 14).

The CBD craze traces its roots to the cannabis reform movement, and it gained momentum when the Farm Bill 2018 became law last year. This bill legalized industrial hemp and all its derivatives, including CBD.

The survey involving 1,017 participants was conducted over the phone in a bid to get insights into the widespread appeal of CBD. The interviews were conducted from May 15-30.

In all, 39 percent of the people polled revealed that they want to see CBD available as an OTC drug while 21 percent said CBD should be accessed using a doctor’s prescription. 36 percent of the people polled revealed that they weren’t familiar with this particular compound of hemp and marijuana plants.

When Gallup focused on those who were familiar with CBD and asked them whether CBD should be purchased as an OTC drug or as a prescription drug, 61 percent favored the OTC option while 33 percent preferred to see it as a prescription drug.

The participants in the poll were also asked to rate how familiar they were with CBD. 14 percent looked at themselves as “very familiar” with it, 33 percent felt they were “somewhat familiar”, 17 percent felt they were “not too familiar” while 36 percent confessed that they “weren’t familiar at all” with cannabidiol.

Gallup again narrowed its attention to only those who categorized themselves as very familiar with cannabidiol and asked them for their opinion about the medicinal value of CBD. 90 percent of this group believed that CBD had therapeutic benefits.

Of those who thought CBD had medicinal benefits, 33 percent said it had “a lot of benefits”, 45 percent felt CBD had “some benefits” and 14 percent thought cannabidiol had “a few benefits.” 3 percent were neutral on the matter while 4 percent said cannabidiol didn’t have any medical benefits.

Commenting about their findings, Gallup wrote that most Americans already believe that CBD has medicinal value even if research has been slow in proving or disproving many of the therapeutic benefits attributed to CBD. Gallup is convinced that the fraction of people who think CBD is medicinal is most likely to grow as more people get exposed to this non-psychoactive compound.

This possibility takes on a greater degree of certainty given that the FDA has already been convinced enough of CBD’s therapeutic benefits to the extent of approving a drug targeting rare forms of epilepsy.

The pressure on federal agencies like the FDA and Congress to pass laws legalizing CBD as a food supplement and other uses is therefore going to increase as the months go by.

Cannabis industry analysts are of the opinion that the Gallup findings didn’t catch industry players like Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) and Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) by surprise.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The House Rules Committee of Congress is set to hear almost a dozen amendments related to marijuana this week. This crucial committee will decide which of those amendments are cleared for a vote by the whole House. The amendments are being considered this week because those that pass will form part of the appropriations bill for funding sections of the federal government in the next fiscal year.

Rep. Tom McClintock (R-CA) and Earl Blumenauer (D-OR) have reintroduced an amendment intended to prevent the Department of Justice from using its budget to get in the way of states which have enacted their own marijuana laws. An existing spending rider only covers medical marijuana, but the proposed amendment takes this further and seeks to protect state-level recreational marijuana as well. This new amendment is similar to another which failed by just nine votes in 2015.

Another amendment before the committee was introduced by Rep. Stacy Plaskett (D-VI). This measure is intended to correct the inadvertent omission of the U.S. Virgin Islands from the list of states and territories whose medical marijuana programs are protected from Justice Department interference by a spending rider.

Rep. Blumenauer didn’t stop at the amendment he co-authored with McClintock. He also brought several other amendments on his own. One amendment seeks to bar the Department of Justice from interfering in the tribal medical marijuana programs even if the states in which those tribal communities are found haven’t enacted medical cannabis laws. Three other amendments filed by the legislator also protect tribal marijuana programs in various ways.

Two other amendments by Blumenauer touch on the Department of Veteran Affairs. One protects VA workers from being penalized for filing paperwork in compliance with state laws regarding medical marijuana. Another aims at protecting VA doctors from being penalized for any marijuana-related work they do in states where medical marijuana is legal.

The Rules Committee will also consider a measure tabled by Rep. Ocasio-Cortez (D-NY) seeking to divert $30 million from the funding allocated to the DEA. This money should go towards the Comprehensive Opioid Abuse Program. In this way, the DEA will fall in line with the current thinking that drug addiction is a public health concern rather than a crime.

Rep. Jerry McNerney (D-CA) has also tabled an amendment containing a spending proposal for the FDA to undertake a process through which CBD (cannabidiol) will become legal as an additive in food supplements and conventional foods.

It is interesting to note that many of the amendments seem to be geared at introducing marijuana policy reforms using the appropriations process. The success of the spending rider placed on the DOJ years ago appears to have provided an example that advocates want to use to initiate incremental changes to the existing marijuana policies.

Analysts wonder what major cannabis industry entities like Net Element Inc. (NASDAQ: NETE) and Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) think about this change in strategy.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has taken a similar path with the acquisition of Newstrike. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is building a positive public profile through releasing educational tools. Aphria Inc. (TSX: APHA) (NYSE: APHA) has expanded the hunt for cultivation licenses to Germany. Meanwhile, companies such as Charlotte’s Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF) keep releasing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The Veterans and Legal Affairs Committee of Maine’s Assembly has voted 7-2 approving the draft rules for the legalization of recreational marijuana in the state. The approved rules relax the residency requirements included with the purpose of keeping out-of-state companies from moving in and controlling the recreational market at the expense of local companies.

The committee removed language that limited out-of-state players from having majority stake in recreational marijuana companies which operate within Maine. In its place, the committee left a provision to the effect that Mainers who have resided in the state for at least four years will have 51 percent ownership of any company to be licensed to conduct business in the recreational marijuana arena. This means that the local ownership can be several individuals or entities as long as their combined stake adds up to 51 percent in the company.

Erik Gundersen, the head of the Office of Marijuana Policy, said his office wants to see the tools which will make it possible for the letter and the spirit of the law to be implemented. He added that the law should be made by Mainers, within Maine and for the benefit of Mainers.

The Maine Office of Marijuana Policy was instrumental in including language which specifically sought to lock out large corporations from using out-of-state management contracts to dominate the local recreational cannabis market in the fashion of what is happening in Massachusetts and even in the medical marijuana program of Maine.

However, not everyone was thrilled with that proposal to lock out out-of-state companies. Some people said that the provision would be counterproductive because it would hurt the interests of Mainers in the long run since the capital and technical expertise of out-of-state operators was needed to kick-start the recreational marijuana industry. They cited the example of manufacturing equipment which costs millions and would be out of reach for most local investors.

Wellness Connection of Maine, the biggest medical marijuana company in the state, had even threatened to sue the regulator if the original text of the bill was retained in the final language of the law. The company felt that the provision about out-of-state companies was targeting it since it has complex management contracts with out-of-state operators.

The time at which marijuana companies should close their doors also generated a lot of debate in the committee. The original bill stipulated that retail outlets should close at 9pm, but this was changed to 10pm to avoid sending people to black market players. Law enforcement agencies had pushed for the 9pm closing time.

The committee decided that local authorities shouldn’t have the right to set their own operating hours for cannabis businesses. However, cannabis businesses could apply to open for extended hours and the regulator would consider their request on a case-by-case basis.

Now that the bill has been cleared by the committee, advocates hope that the entire House will vote on it before the legislative session ends on June 19.

Marijuana industry analysts hope that the cannabis industry, including players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and VPR Brands LP (OTC: VPRB), will be happy that a robust debate was conducted and the strongest arguments won the day during the committee session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the countdown to the end of this legislative session in New York State enters the final stages, plans to legalize recreational marijuana have been revived with the possibility of a vote on the matter this week.

While momentum to get recreational weed legal appeared to fade once lawmakers in New Jersey announced that they were giving up on trying to use legislative means to end prohibition, advocates in the Empire State are brimming with optimism that lawmakers may have reached a deal and the bill will pass.

Democrats in both the Assembly and Senate held conferences last week in a bid to discuss the fine print of the legislation. Sources close to those who attended these meetings reported that the conferences went well and that the bill may have enough support to sail through.

On Saturday last week, the staff of the legislative leaders in Senate and the Assembly met those from Gov. Cuomo’s office to talk about the final language of the bill which will be put before lawmakers within the last days of the legislative session.

Earlier on Wednesday last week, the senate version of the legalization bill was given the “same as” status indicating that its language was identical to the language of the version in the Assembly. This is an indicator that both chambers agreed on the wording of the bill, and that is an early indicator of possible success when a vote is called.

The speaker of the Assembly, Carl Heastie (D), revealed on Friday that the Democrats hadn’t yet decided on whether to bring the matter to the floor of the House but added that the bill had support among the Democratic members of the chamber. Despite the optimism, analysts think that the bill is still short by two votes in the state Senate.

Sensing that the bill may soon be up for a vote, key state officials have been urging legislators and the governor to include a given list of provisions in the final text of the bill.

Letitia James (D), the State Attorney General wrote that the bill should include provisions to expunge all previous convictions for non-violent marijuana crimes.

NYC Mayor Bill de Blasio (D) also pushed for expungement and added that the bill legalizing recreational marijuana should aim at empowering local businesses rather than big corporations.

The district attorneys of Albany County and Manhattan jointly wrote an op-ed urging lawmakers to end what they called “staggering inequities” and also promote public safety by enacting the bill to legalize recreational marijuana.

The legislative session will end on Wednesday, so lawmakers have a narrow window within which to schedule a vote in both chambers.

Industry watchers have been wondering whether marijuana industry players like SinglePoint Inc. (OTCQB: SING) and Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FRA: O3X4) experience as much tension when a major decision is due as what the people of New York State are experiencing in these final days of the legislative session.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?

Quarter-over-quarter sales growth is one of the indicators used to target explosive upside potential. Similar growth patterns were exhibited by many of the cannabis behemoths prior to parabolic price increases. In what may be an equally telling indicator, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) revenues have now increased 11 consecutive quarters, quarter on quarter, ever since the company started selling its hemp-based CBD products. Similar quarterly sales spikes and strategic acquisitions foreshadowed dramatic price increases in some of the largest names in the cannabis universe. Last October Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) soared 60% in one week when the company announced a deal to buy PharmCann. Florida-based Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL) went public last September through a reverse merger in Canada and soared 200% after a strong 2018 Q2. Already up big on Canadian exchanges, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) became the first pure-play marijuana stock to list on NASDAQ around $7 and just bounced off $23 a share. Last year, Tilray Inc. (NASDAQ: TLRY) became the first cannabis company to…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Activists in Mississippi have revealed that they are about to reach the required number of voter signatures in order to see an initiative about medical marijuana included on the ballot in 2020.

Once the organizers submit that list of signatures, the Secretary of State will go through it and certify that each of the signatures belongs to a valid voter in the state. The organizers have emphasized that they will not stop once they reach the minimum number of signatures required. Instead, they will keep gathering more until the submission deadline in September is reached. The extra signatures will serve as an insurance policy just in case some of the signatures collected are deemed invalid. So far, about two-thirds of the required number of signatures have already been collected.

State law requires that if the petition is to be included on the ballot, it must be supported by at least 86,185 registered voters across the state. Additionally, the law also sets minimum numbers of signatures that have to be collected from each of the Congressional Districts in Mississippi.

The initiative for which signatures are being collected seeks to create a law under which patients suffering from debilitating conditions can consult their doctors and obtain a recommendation to use medical marijuana.

22 qualifying conditions, including PTSD, cancer, chronic pain and epilepsy have been suggested as conditions for which patients can use medical marijuana. Patients who get recommendations from their doctors and are registered by the state will be eligible to buy a maximum of 2.5 ounces of medical cannabis within a two-week window.

Currently, the state only allows a limited number of patient categories to use CBD oil to manage their health conditions. This oil has to be purchased from a few highly regulated suppliers whose products have been subjected to rigorous testing at the National Center for Natural Products Research.

The NCNPR is based at the University of Mississippi where the only federally approved manufacturing facility for research-grade cannabis is based.

If the medical marijuana initiative makes it onto the ballot and gets the approval of voters, the Department of Health will be responsible for establishing and regulating a more robust system through which patients can access medical marijuana.

The steps taken to get medical marijuana on the ballot in Mississippi follow the regional trend which has seen several states make marijuana law reforms. Texas has decriminalized marijuana possession and passed a bill to expand its medical cannabis program. Similarly, Alabama’s legislature recently passed a bill to legalize medical marijuana while Georgia also expanded its medical marijuana program.

According to analysts, the positive changes in this region of the U.S. could signal to industry players like MustGrow Biologics Corp. and Marijuana Company of America Inc. (OTCQB: MCOA) that the entire country may soon embrace marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Competitive Enterprises Institute, a libertarian think tank, has claimed in a formal filing that the federal government erred in the way it handled the scientific evaluation of cannabis’ therapeutic value, and the government must therefore take steps to fix the errors it made.

Their request for correction was sent to the Department of Health and Human Services (U.S. HHS). HHS had written to the DEA in 2015 and the DEA relied on that letter from HHS in determining that marijuana be classified as a Schedule 1 drug in the U.S.

According to CEI (Competitive Enterprises Institute), the letter sent by HHS lacked a very important element which is required by federal law. The federal Information Quality Act demands that such “highly influential scientific assessment” as the contents of the HHS letter to the DEA be subjected to a peer review evaluation before the information therein can be relied upon when making regulatory decisions.

No such peer review was conducted, and the CEI is demanding that HHS withdraws its letter to the Drug Enforcement Administration until the requisite peer review exercise has been done as stipulated in the law.

The DEA leaned heavily on the contents of the letter written by HHS to the effect that “marijuana has no recognized medical use in the U.S., has a high potential for abuse and doesn’t have an acceptable level of safety even when used under medical supervision.” Based on this information, the DEA rejected an application which had been made to have marijuana rescheduled in 2016.

In its letter to HHS, CEI points out that various medical associations and a huge fraction of the public in the U.S. have formed a largely different conclusion about marijuana. By law, HHS now has a maximum of 120 days within which to respond to the concerns raised by the Competitive Enterprises Institute.

Devin Watkins, an attorney for CEI, says that the federal government’s policy is likely to change if a reassessment of the matter is conducted. This is especially likely given that 33 states across the country have legalized marijuana for medical use.

The attorney added that the reassessment would be significant in ensuring that government agencies don’t brand uninformed opinions as scientific positions upon which public policies are made. Independent experts can shine a torch on the opinion of an agency and correct it if a mistake has been made.

Industry observers suspect that the entire cannabis industry, including players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Hemptown USA, are likely to follow keenly how HHS responds to the letter written by CEI.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

From the first day of 2020, no employer in Nevada will be allowed to deny a job applicant employment just because that individual tested positive for marijuana during a pre-employment drugs test. The ban is contained in a bill which was signed into law by Gov. Sisolak on June 5. This makes Nevada the first state to enact such legislation in the country.

The new law contains some exceptions for people who may be denied employment on the basis of pre-employment marijuana screening. These include firefighters, EMTs, those who operate vehicles, federal government employees and anyone else applying for a job that the employer deems to be safety-sensitive.

The law also states that when an employer requires a prospective hire to be tested for marijuana, that potential employee has the right to have another test done within 30 days and the employer is bound to accept the results of that additional test. This extra test is at the expense of the prospective employee, according to the newly signed law.

Gov. Sisolak said that he was happy to sign AB132 because the cannabis industry in Nevada was growing and there was need to pass appropriate laws so that all residents of the state remain eligible to take advantage of all the opportunities available. He added that the exceptions included in that law are a matter of commonsense since matters of public safety and transportation have to be taken seriously.

This law has been regarded as long overdue by cannabis advocates since it was naturally expected that positive test results during pre-employment drugs screening would increase after the state legalized recreational marijuana in 2016 and commercial sales started a year later for adults 21 and older.

The law passed and enacted in Nevada is similar to the bill which was passed by the New York City Council in April this year. That bill banned employers from demanding that job applicants pass a drugs test for marijuana as a condition for being employed.

In Maine where recreational marijuana is legal, state law bans employers from discriminating people based on whether they use or don’t use marijuana. However, there is no specific provision banning marijuana testing during the employee hiring process.

Now that Nevada has paved the way, many other states are likely to ask themselves why they hadn’t thought of passing such a law since it is only logical that once recreational marijuana is legal, adults will legally use it and it would be unfair to deny them jobs because they used a legal substance.

Industry commentators would be glad to hear what different companies in the cannabis industry, such as Green Hygienics Holdings Inc. (OTCQB: GRYN) and Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), have to say about the developments in the cannabis industry in Nevada.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The state of Colorado has now pocketed more than $1 billion in revenue from the legal cannabis industry. This marks yet another milestone for the state which legalized marijuana in 2014.

According to marijuana sales data which has just been released by the state, cannabis sales hit the $6.5 billion mark at the end of May this year. The data also shows that the sales of recreational marijuana are continuing to rise higher as the months roll by.

April and May 2019 have also been the best months so far in the entire history of the cannabis industry in Colorado with the monthly state revenue reaching the highest level ever at $24.2 million in April. The state took approximately three and a half years to reach cannabis sales totaling $500 million, but the state was able to double that figure in less than two years to cross the $1 billion mark.

Since July 2017, the revenue collected by the state from the cannabis industry has never gone below $20 million each month. This shows massive growth given that the total state revenue from marijuana in February 2014 was just $3.5 million.

Speaking at a Net Net event in Denver on May 1, Gov. Polis revealed that the marijuana industry was doing very well because it had created “tens of thousands of jobs, reducing crime, filling up buildings and bringing state revenue.”

Speaking of creating jobs, there are 41,076 people who have licenses to work in the Colorado cannabis industry. It is reasonable to conclude that nearly all those people are indeed employed in the industry since the licenses are renewed every two years and it wouldn’t make sense for someone to pay for and renew a license if they aren’t working in the industry.

Gov. Polis wants to see the cannabis industry take even bigger strides and take full advantage of its trailblazer status across the country. He knows that cannabis sales will never equal those in bigger states, such as New Jersey and California, so he has set his sights on other ways through which Colorado can remain a leader in the industry. For example, he wants to see cannabis point of sale systems, cannabis genetics and cannabis chemistry innovations headquartered in Colorado from where other states are served by those companies.

With sales and state revenues hitting such highs, who would blame the governor for dreaming big? The situation in Colorado is far different from other states, such as California, where the legal cannabis industry is struggling under the yoke of high taxes, a vibrant black market and legal battles with local authorities and cities which have banned marijuana sales in their jurisdictions.

If only one could be a fly on the wall and hear what goes on in the corridors of companies like Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR) as they talk about the contrast between what is happening in Colorado and in California!

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Experiments with next-generation delivery systems appear certain to lead to better cannabis-based products.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has recently seen spectacular improvements in the effectiveness of cannabinoids thanks to its proprietary chemical delivery treatment. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF), which has won widespread praise for its innovative medical work, has seen good trial results for a new treatment for seizures.  Tilray Inc. (NASDAQ: TLRY) is supporting studies into the uses of cannabinoids to treat behavioral problems and HIV. MariMed Inc. (OTCQB: MRMD) has set up a subsidiary focused on CBD, currently the highest-profile cannabinoid product. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has established a new research lab to develop devices for CBD consumption.

To hear the CannabisNewsAudio version, visit http://cnw.fm/My9kX

To view the full editorial, visit http://cnw.fm/Od8IU

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Extraction technology plays a crucial part in the production of cannabidiol (CBD) from hemp.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a company already established in the hydroponic equipment business, is making plans to add extraction technology to its repertoire. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has been researching new medical applications for CBD and related chemicals — medicines for which extraction will be critical. KushCo Holdings Inc. (OTCQX: KSHB)has moved from providing support services to CBD-related companies to running its own store and has recently bolstered its leadership team for further growth. Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) has expanded swiftly over the past six years, growing from a single operation to a presence in five U.S. states. And in a boost to CBD’s public profile, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has teamed up with UFC to research the application of CBD and related treatments for mixed martial artists.

To hear the CannabisNewsAudio version, visit http://cnw.fm/48P8p

To view the full editorial, visit http://cnw.fm/Sai9c

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

If you were wondering how fast marijuana could become a mainstream substance, the Church of England has just provided further proof that this once heavily stigmatized plant is getting the recognition and acceptance that it deserves. The Church of England has instructed its number crunchers to start making investments in medical marijuana companies.

In the past, the Church Commissioners for England (the entity which manages the $16 billion investment portfolio of the Church of England) rigidly adhered to their self-imposed policy of not holding stocks in cannabis companies.

The new policy allows the Church of England to hold stocks of medical marijuana companies. Recreational cannabis is still a no-no and any company which obtains more than 10 percent of its revenue from the sale of recreational cannabis is off-limits for the Church of England.

Edward Mason, the head of responsible investment at the Church Commissioners for England confirmed that they “make a distinction between recreational and medicinal cannabis” and are content with marijuana being used for medical purposes. Mason concluded by saying that the Commissioners for England are happy to invest in medicine.

The Church Commissioners for England have a huge reputation for their “ethical” investment decisions. They will only invest in companies which meet their strict definition of what constitutes Christian values. Consequently, the group will never invest in industries of questionable moral character, such as pornography, gambling and tobacco. Marijuana, or at least its medical side, is now acceptable to the group.

The decision by the Commissioners for England to start investing in medicinal cannabis is a huge step forward in the eyes of patients using medical marijuana because it helps to put a dent in the wall of stigma which those patients have to deal with on a daily basis.

Many people regard anyone using cannabis as stoner, even if the person is consuming medical cannabis purely for therapeutic purposes rather than for the recreational purposes. This stigma has compelled patients to resort to hiding while they are taking medical marijuana, and others have restricted themselves to more discreet modes of administration, such as edibles and suppositories.

Medical marijuana patients therefore hope that the step taken by the Church of England is followed by all the other religious denominations. In this way, medical marijuana will get the broad acceptance which it deserves as a form of medicine.

Both laypeople and cannabis industry analysts wonder how the more favorable direction taken by the Commissioners for England regarding medical marijuana will impact the future plans of industry participants like Earth Science Tech Inc. (OTCQB: ETST) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF).

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The legislature in Oregon has voted to approve a law which will see the marijuana convictions of tens of thousands of Oregonians expunged so that those individuals can have a better chance at finding jobs, getting an education and having access to housing.

Senate Bill 420 seeks to clear all marijuana convictions which are no longer crimes from the time marijuana was legalized in the state in 2014. This means people who were prosecuted and convicted prior to 2014 can have their slate wiped clean.

This bill was initially approved by a 25-4 vote by the Senate in April. However, the bill was modified when it was taken to the Assembly, so the modifications were brought back for approval by the Senate. The State Senate repassed the bill with a similar 25-4 vote. What is now left is Gov. Kate Brown’s signature so that the bill becomes law.

It isn’t immediately clear how many people are eligible to have their criminal record wiped. This is because in the past, court records didn’t reflect the specific controlled substance that an accused person was charged with.

However, estimates put the number of people who were convicted for marijuana possession at about 20,000-75,000 individuals.

Once this bill becomes law, anyone who was convicted for a marijuana crime that is no longer in the law books can fill out a form asking to have their conviction expunged.

Sen. Lew Frederick (D-Portland) supported the bill and says it was long overdue since marijuana convictions follow someone throughout their life and make it hard for that person to get housing, find a job or get an education.

In a related development, the Oregon House also passed a bill granting the state governor authority to negotiate agreements with other states for the purpose of exporting Oregon’s excess marijuana as soon as the federal government tolerates or legalizes interstate marijuana commerce. This bill was passed on the same day (Tuesday, June 11) that the expungement bill was passed.

Supporters of Senate Bill 582 say that Oregon is being forward looking by passing enabling laws in preparation for federal reform of cannabis policies. Some even said that this bill isn’t an endorsement of the cannabis industry, but rather provides support for the business community since exporting marijuana would create more jobs and bring revenue into Oregon from the states with which it is trading.

It should be remembered that Oregon has a massive surplus of marijuana, and some people say about six years are needed to consume this excess if current demand levels are maintained.

However, opponents of SB 582 say that the bill is of no consequence since it is akin to hiring a financial advisor simply because you expect that you will soon win the lottery.

Analysts wonder what cannabis industry players like Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and ChineseInvestors.com Inc. (OTCQB: CIIX) have to say about the export bill passed by Oregon’s Senate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

At this year’s Cannabis Business Summit & Expo – the sixth such event hosted by the NCIA – discussion of the Secure and Fair Enforcement (SAFE) Banking Act is likely to be on the agenda, as well as many other critical issues that are currently affecting the cannabis industry. With its return to San Jose, the location of last year’s event, the nation’s most influential, award-winning cannabis conference and trade show continues to act as a catalyst for innovation in the space and pave the way for cannabis commerce.

The celebratory gathering, scheduled to take place from Monday, July 22, to Wednesday, July 24, at the San Jose McEnery Convention Center, will bring cannabis executives, investors and…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

According to a new policy which has just been made public by Transport Canada (the federal transport regulator), flight crews as well as other industry employees will no longer be allowed to use marijuana within 28 days before they are due to fly.

The policy, which was announced on Thursday (June 6), takes immediate effect and it affects cabin crew, pilots and air traffic controllers. This policy was released in order to clarify the position of the regulator when recreational marijuana was legalized on October 17 last year.

Transport Canada asserted that aviation industry employees are required to maintain a certain minimum “level of fitness for duty” during the time when they are at work. Those employees must therefore refrain from using or being under the influence of any substance which can impair their faculties to a degree that can compromise aviation safety, the regulator added. Transport Canada also affirmed that their policy decision was informed by the current science available on the matter.

The announcement by Transport Canada isn’t altogether new in the Canadian aviation industry. The policy announcement comes after commercial airlines in the country, such as Westjet and Air Canada, had already issued blanket bans to their staff regardless of whether the employees wanted to consume recreational marijuana when they are off duty.

Speaking about Westjet’s radical policy on marijuana, the airline’s spokesperson said that the policy reflects the airline’s position as a leader in aviation safety, and that was why they were requiring Westjetters to report for duty while fit and stay that way throughout their shift.

Transport Canada has chosen to take the path similar to what the Department of National Defence decided to take on recreational marijuana. The military rules were updated to state that any serving military officer who wishes to use recreational marijuana should not do so within eight hours of starting their shift on duty.

The military rules also state that any personnel who operate weapons or vehicles aren’t allowed to consume recreational pot 24-hours before reporting for duty. Those that engage in high-altitude parachuting and those who serve on military aircraft are banned from using recreational cannabis in the 28 days prior to reporting for duty.

The Royal Canadian Mounted Police also announced earlier that any of its personnel who serve in “safety-sensitive positions” are prohibited from using cannabis 28 days prior to reporting for duty.

It would be interesting to know what companies like Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) think about these policies announced by aviation companies and regulators.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The big pot stocks in Canada, such as Tilray Inc., Canopy Growth Corp. and Aurora Cannabis may soon have to contend with an emerging threat as marijuana growers in North America start moving their farms across the border to Columbia.

This migration is eerily similar to what happened to the growers of rose flowers who all moved south to low-cost Columbia.

Paul Henderson, the owner of Grupo Flor (a cannabis cultivation company based in Monterey) is the trailblazer of this migration. He predicts that North American marijuana growers in Canada will suffer the same fate that rose growers experienced. Practically no rose grower was left in Monerey once cultivation starting moving south.

Henderson adds that within the next decade, the cannabis industry will transition into a phase of commoditization. As that happens, it will become increasingly untenable to keep growing marijuana in Canada when Columbia is just a short distance away.

Henderson’s company is currently getting a 1,000,000 square-foot cultivation facility ready on the outskirts of Cali, a city found close to the Equator in Columbia. He boasts that when the facility starts operations, his company would be able to cut the price of its produce by 90 percent and still make a profit, something that growers who are still based in Canada cannot do and stay afloat.

Columbia enjoys several advantages which are only a dream to Canadian cannabis growers. First, the climate in Columbia is so good that the cultivation facilities there don’t require elaborate climate-control systems. Secondly, the labor in Columbia is highly skilled yet more affordable than what is available in Canada.

These reduced production costs put Columbia firmly on course to attain the target of producing a gram of cannabis at just 50 Canadian cents ($0.38) and yet the long-term goal of cannabis production in Canada is to bring the cost of a gram down to CAD $2 ($1.51) . That is a whole world of difference in production costs!

Columbia legalized medical cannabis for domestic use as well as export. This policy shift is responsible for the interest of Canadian cannabis growers in shifting their operations to Columbia.

The emergence of Columbia as a destination for Canadian cannabis cultivators has come at a time when the cannabis industry in Canada has just been dealt a blow by the U.S. FDA. The regulators are reluctant to legalize CBD and it appears to be headed for regulatory oversight by the FDA. This has dampened the hopes of Canadian firms that were gearing up to enter the U.S. CBD market.

Cannabis industry watchers are wondering what major players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International Inc. (NASDAQ: YGYI) can do to respond to developments like transferring marijuana cultivation facilities to another country different from the country where the company has its major operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Experiments with next-generation delivery systems appear certain to lead to better cannabis-based products.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has recently seen spectacular improvements in the effectiveness of cannabinoids thanks to its proprietary chemical delivery treatment. GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF), which has won widespread praise for its innovative medical work, has seen good trial results for a new treatment for seizures.  Tilray Inc. (NASDAQ: TLRY) is supporting studies into the uses of cannabinoids to treat behavioral problems and HIV. MariMed Inc. (OTCQB: MRMD) has set up a subsidiary focused on CBD, currently the highest-profile cannabinoid product. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has established a new research lab to develop…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: Extraction technology plays a crucial part in the production of cannabidiol (CBD) from hemp.

Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a company already established in the hydroponic equipment business, is making plans to add extraction technology to its repertoire. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has been researching new medical applications for CBD and related chemicals — medicines for which extraction will be critical. KushCo Holdings Inc. (OTCQX: KSHB) has moved from providing support services to CBD-related companies to running its own store and has recently bolstered its leadership team for further growth. Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) has expanded swiftly over the past six years, growing from a single operation to a presence in five U.S. states. And in a boost to CBD’s public profile, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has teamed up with UFC to research the application of CBD and related treatments for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

One of the biggest issues that has stood in the way of medical marijuana patients and healthcare professionals has been the challenge of how to determine the precise dosage to be administered in order to attain the required therapeutic effects. Additionally, it has been hard to find cannabis products whose potency is uniform in order to trigger repeatable outcomes in patients. To compound matters even further, CBD normally brings therapeutic effects at a certain specific concentration. Anything greater or lower than that optimum level reduces its efficacy. The marijuana industry has responded to these challenges by getting more clinical and scientific.

Stratos, a cannabis company based in Colorado, is one of those entities which have stepped up to provide medical cannabis products that are consistent in terms of potency. Their products are so precise that splitting a tablet in half is a guaranteed way to take just half of the dose indicated on the product label.

Charlotte Payton, the VP of Development and Co-founder of Stratos, revealed that the company leveraged the roots of its founders in the medical arena to find ways to bring the consistency which is a given in other industries to the medical cannabis space. She wondered why people would easily get reliability and consistency in pharmaceuticals but not cannabis. Strato’s solution addressed that issue.

GoFire is another healthcare technology company which is also blazing a trail in finding solutions to deliver consistency in the medical cannabis industry. One of the products which they have brought to market is called the GoFire Inhaler. The inhaler’s unique convection heating system, precision dosing mechanism and medical-grade materials and design have just been patented.

The inhaler made by GoFire was designed for medicines extracted from plants, so patients can use this product to take cannabis flower and concentrates. Buyers of the inhaler also get an app which allows them to track and document their dosage preferences in addition to connecting with a community of other users of the GoFire Inhaler.

The work of these two companies has been welcomed by both medical professionals and patients. One such professional who was full of praises for the inhaler is Denver-based Dr. Michael Keller. He said such devices help to ease some of the concerns that members of the medical community have about prescribing medical marijuana products. The possibility of recommending exactly how much a patient should consume at a given frequency brings medical marijuana closer to what is expected of any therapeutic product.

VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) applaud the innovations introduced by Stratos and GoFire since these technologies will bring medical cannabis closer to becoming a mainstream way to treat or manage different health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Hope for Health, a Toronto-based charity, has been launched as the first cannabis charity registered by the Canadian government. The charity is registered in the category of organizations whose intention is the “advancement of education.”

Hope for Health says it aims to enable patients to manage their health effectively while also giving them the autonomy to choose which cannabis products and cannabis producers to deal with.

The charity kick-started its operations amidst fears that medical marijuana patients are getting reduced attention as more attention is directed towards the recreational market. This is seen in the rising medical marijuana product prices. Access points for medical cannabis are also reducing while a new excise tax on marijuana prices has also been imposed on medical marijuana products. This excise tax can only be waived on the product price if the company selling medical marijuana products opts to absorb that cost.

To alleviate this increased cost of medical marijuana products, Hope for Health has decided to avail a renewable monthly stipend to patients who meet the eligibility criteria of the charity. This stipend is conditioned upon the patient purchasing their medical marijuana products from one of the 170 producers licensed by the Canadian federal government.

Hope for Health intends to take on at least 150 patients during its first year of operation. More patients will be onboarded each year and the number will vary depending on the resources available as well as the level of interest displayed by patients.

The charity doesn’t only have its eyes on patients. Hope for Health plans to create and disseminate educational materials to health care professionals about the medicinal benefits of marijuana. This will be done in conjunction with creating partnerships with research organizations, academic institutions and medical associations.

Hope for Charity is the brainchild of Auxly Cannabis Group, an entity that provides financing to cannabis cultivators. Auxly Cannabis Group has committed itself to availing funding that they are calling “a cornerstone donation.” The funds will be used to get the charity on its feet.

Hugo Alves, the director of Hope for Health, remarked that the idea of the charity was conceived three years ago. The founders felt that every entity which had reaped from the cannabis industry in the country would rally around the idea and support its operations.

The founders also strongly felt that the leadership and management of the charity should be independent if Hope for Health is to retain its appeal to all players in the industry. To this end, they selected Dr. Jenna Valleriana as the Executive Director of the charity.

Dr. Valleriana is a respected cannabis policy expert who heads the National Institute for Cannabis Health and Education. She recently published a cannabis education toolkit which was used by two other organizations to design digital tools aimed at educating students and parents about marijuana.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) commend the people behind Hope for Health and wish them all the best in their noble undertaking.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

• Hemp seed genetics are critical to hemp farming success
• Cannabigerol (CBG) is emerging as a valuable cannabinoid with multiple potential health benefits
• Hemptown USA is growing one million rare cannabigerol-dominant plants designed to yield up to one million pounds of CBG biomass

High quality seeds are a key prerequisite for growing healthy, strong cannabis plants. The right seeds can deliver the right cannabinoid profile, increase resilience and help for achieving sufficiently sustainable yields.

Companies like Hemptown USA are pioneers in the farming of novel cannabinoid strains in addition to cannabidiol (CBD). In 2019, the company acquired $5.5 million worth of Oregon CBD Seeds, including one million rare…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

After the NFL announced that it was studying the possibility of using marijuana as a pain treatment for players, the NBA Commissioner Adam Silver has revealed that they too are considering the matter.

While the Commissioner was non-committal about when the rule changes would be made, he did admit that the matter was up for discussion with NBAPA (NBA Players Association).

Any changes to the marijuana rules of the NBA can only come as an inclusion in the collective bargaining agreement signed with the players association. However, the commissioner says that the players haven’t reached a consensus on the matter, so more discussions are needed to get everyone on board.

Commissioner Silver revealed that some players are concerned that if a teammate gets on the court while high on marijuana, such as player could let down the entire team by not giving the game their all.

Silver also said that in his opinion, there was nothing wrong with a player taking some cannabis as a way of winding down after a major game. To him, this is no different than taking a drink, and he feels that the NBA hasn’t moved with the times in permitting such social use of marijuana.

Silver is also open to looking into the medical uses, such as pain relief, of cannabis for NBA players. This is major attitude shift from the position he held two years ago when he told the press that he saw no need to amend the NBA policies to accommodate medical marijuana.

While the commissioner hasn’t made any firm commitments regarding reforming the cannabis policy of the league, the good news is that he is open to the possibility. However, any changes to be made are likely to take a few more years before coming into force since the current collective bargaining agreement with the association of players is still in force until the 2023/24 season comes to an end.

All the same, the fact that the NBA and other sports associations are looking into the potential benefits of marijuana is good news to advocates since such associations have always been notoriously conservative.

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) hope that the NFL updates its marijuana rules next year as is widely expected. This will open the way for other associations to follow this lead and update their own policies as well so that players enjoy the benefits of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Sherry Hoover, a retired nurse suffering from stage 4 cancer, has taken Michigan to court to challenge its newly imposed medical marijuana testing rules. The lawsuit filed in a federal court seeks to obtain a temporary restraining order so that the plaintiff can continue accessing her marijuana-derived medicine which has since become hard to obtain due to the new testing rules imposed by the state regulator.

The 57-year old plaintiff was diagnosed with mastocytosis leukemia in 2011. She used several prescription drugs, such as fentanyl patches and Norco, with limited effect until she discovered that medical marijuana could improve her appetite, alleviate her pain and enable her to sleep better.

Before April 1 this year, LARA (Licensing and Regulatory Affairs) permitted untested medical marijuana products to be sold in medical marijuana dispensaries. However, those untested tinctures, oils and other medicinal products made by registered caregivers would no longer be sold without being tested once the April 1 deadline passed.

The testing rules have since taken effect, and Hoover is finding it hard to access the products which have been instrumental in giving her a better quality of life. The lawsuit she filed on Wednesday (June 5) seeks to compel the state to extend the commencement of enforcing the testing rules to December 31.

She argues that the current restrictions have resulted in stock-outs in the only two licensed medical marijuana dispensaries which carried the products she uses. Continuing to enforce the testing rules may therefore leave her with no choice but to resort to the black market for her medicine, a step she doesn’t want to take.

The suit states that the four licensed testing facilities cannot cope with the demand for testing services from licensed cultivators, manufacturers and caregivers. Additionally, the added steps, such as transporting the untested products to the testing facilities and then hiring transport firms permitted to carry tested products to medical marijuana dispensaries prolongs the duration needed to get tinctures and other medical marijuana products made by caregivers to the dispensing points where patients can buy them.

In short, Hoover argues in her suit that the state is violating her rights of access to medical marijuana products and yet she is licensed and duly authorized to use such products.

This isn’t the first time that Sherry Hoover is suing the state. Last year, she successfully sued LARA to compel it to extend deadline imposed for unlicensed dispensaries to get the necessary permits or close by December 31, 2018. Her lawsuit was successful and the deadline was extended to April 1 this year.

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and Sugarmade Inc. (OTCQB: SGMD) long for the day when all the kinks in the way medical marijuana is regulated are fixed so that these seemingly endless deadline extensions and lawsuits in Michigan come to an end.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
As the hemp and CBD markets grow, a wide variety of CBD- and hemp-based products are becoming available, including products for pets.

Geyser Brands Inc. (TSX.V: GYSR) (GYSR Profile) has recently announced an acquisition that provides the company with two brands of hemp and CBD products. Indiva Ltd. (TSX.V: NDVA) (OTCQX: NDVAF), which provides infused products for humans, is working on a new extraction facility to increase its production. Viridium Pacific Group (TSX.V: VIR) (OTCQB: VIRFF) is supporting the growth of the hemp and cannabis industries through investment, both in acquisitions and in partnership with smaller companies. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) has raised the public profile of CBD through celebrity associations and entry into prestige shops. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is producing CBD products for both humans and their furry companions.

To view the full editorial, visit http://cnw.fm/i5qlA

To hear the CannabisNewsAudio version, visit http://cnw.fm/X8smi

About Geyser Brands Inc.

Geyser Brands builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food-and-beverage and pet sectors worldwide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers topical, cream, beverages and baked goods, oil, and tincture formulations with superior bioavailability and water solubility. Geyser Brands is a Health Canada-approved licensed producer (“LP”) in Port Coquitlam, British Columbia, that holds a cultivation license and is anticipating its processing and sales licenses. The company is exclusively focusing on leveraging these assets to provide the regulatory infrastructure for its global brands and distribution strategy, acquiring hemp- and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. The company’s proprietary NanoFusion technology surrounds oils and solves for the insolubility of CBD. Geyser Brands will utilize its 7,000-square-foot licensed facility in British Columbia for the manufacturing and international distribution of its hemp- and CBD-based products. For more information, visit the company’s website at www.GeyserBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at  http://cnw.fm/GYSR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Franchising is one of the giant economic forces in the U.S. given the fact that this business model generated approximately $451 billion in 2018. Are we about to see cannabis enterprises built upon this model? Anyone intending to enter cannabis franchising needs to think about and find remedies to the following major bottlenecks.

Conflicts Between State and Federal Laws

Despite the legalization of marijuana for recreational or medical use in various states across the U.S., cannabis remains a Schedule 1 substance at the federal level. This creates major legal issues for businesses which wish to operate franchises in the cannabis industry. For example, a franchise owner cannot ship products across state lines in order to sell the excess products from one state in another state where supply is limited. This makes the possibility of prices nose-diving a real concern since gluts inevitably result in plummeting prices.

Tax Issues

According to the federal tax code, marijuana businesses aren’t eligible for any deductibles on the costs that they incur during the execution of their business activities. For example, marijuana businesses cannot deduct the cost of buying business premises and yet other enterprises which don’t transact in Schedule 1 substances can claim tax deductions on this business expense. These tax disadvantages mean that cannabis businesses will struggle to be profitable unless they can find ways to be super-efficient regarding non-deductible expenses.

Limited Consumer Awareness

Marijuana has been prohibited for long and certain stereotypes about the substance still exist even where prohibition has ended. Cannabis franchisees would therefore have to do a lot to educate their prospective customers in order to make sales on a consistent basis. This added challenge of performing customer education on an ongoing basis isn’t faced by franchises in other industries, such as the fast foods industry.

Limited Investor Interest

Currently, investors aren’t too eager to put their money in an industry which still faces legal uncertainties. This explains why US-based marijuana companies are generally undervalued when compared to their Canadian-based counterparts, for example. While this limited investor appeal exists, any cannabis franchisers that set up shop may struggle to attract investors unless the legal space changes for the better.

In the true entrepreneurial spirit, every challenge presents a business opportunity. The cannabis franchise space is therefore open for the taking for those individuals who devise ways to bring a franchise concept into the cannabis space in a way that ensures that investors will earn a return despite the challenges above. Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) hope that enterprising individuals will take up this challenge and devise franchises which will spur the growth of the cannabis industry even more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A Congressional research body has released a report whose findings bring into question a common assumption which has always been made by legislators that the legalization of marijuana leads to more accidents on roads due to impairment.

The experts, who were instructed by Senate and Congress to study the issue of impaired driving, didn’t find any conclusive evidence that marijuana can cause a driver to be impaired.

While law enforcement agencies have tried and true tools to identify people who are driving while impaired by alcohol, developing similar tools for dealing with marijuana driving impairment has proved to be very challenging.

The problem isn’t just the lack of appropriate technology. Additional questions also exist regarding how much THC can cause impairment and how that impairment is caused. The CRS (Congressional Research Service) writes in its report that while laboratory tests have proved that one can be impaired after consuming marijuana, conflicting results were found when studies were done to ascertain the degree of added risk of fatal crashes resulting from marijuana consumption.

Both opponents and advocates of legalizing marijuana agree that a lasting solution should be found to the issue of how to detect marijuana-impaired driving. However, the experts still doubt whether it will be possible to develop appropriate technology to detect impaired driving since what is currently available can only test whether someone has recently consumed cannabis.

It is remarkable that the Congressional report mentions several times that it isn’t clear cut that marijuana consumption is associated with a heightened risk of traffic accidents. This runs counter to the assumption which has been commonly held by Congress that when marijuana restrictions are loosened, there will be a rise in traffic accident fatalities.

This line of thinking also appeared in the wording of a recent House Appropriations Committee report in which funds were allocated to law enforcement agencies to identify drivers impaired by marijuana as a way of reducing the fatal accidents resulting from the increasing legalization of marijuana by states around the country.

Different researchers have reported that fatalities on the road don’t increase after marijuana has been legalized by a state. However, this doesn’t alter the reality that both sides on the marijuana legalization issue advise against driving after one has consumed cannabis.

The deputy director of NORML explained how hard it is to determine impairment from marijuana. He says that the effects on the psychomotor system are normally less acute and take a shorter time if one consumes marijuana, unlike the opposite case after alcohol consumption. Furthermore, THC remains detectable for a longer time, so a positive test doesn’t prove that one is impaired or consumed cannabis recently.

The Congressional researchers offer a number of recommendations on what Congress can do in light of the information gathered by the researchers. One recommendation is that more research should be done to determine whether a quantitative standard is feasible when determining cannabis impairment.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4), Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) welcomes the report of the Congressional Research Service because it helps to dispel some of the misconceptions about marijuana use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

According to a notice published on Monday (June 3), Rhode Island hopes that blockchain technology can be harnessed to help the state to track medical marijuana and identify illegal actors.

The state has called on blockchain technology developers to submit concepts from which the state will select a provider to develop a system that is customized for the medical marijuana program in Rhode Island.

In a press release, the department of Business Regulation revealed that the call for concepts is a challenge to the blockchain companies to showcase their value to government institutions by testing blockchain technology applications within government entities.

The notice published was categorical in stating that Rhode Island was seeking technology which would increase the visibility of the medical marijuana industry from seed to sale so that opportunities for fraud and abuse could be reduced.

Additionally, blockchain technology could also assist different government agencies in designing an authoritative record of the chain-of-custody during the gathering of evidence while criminal investigations are conducted. This is particularly needed for the enforcement of marijuana laws.

Rhode Island looks at this as the first step towards understanding how blockchain technology can facilitate the improvement of government processes now and in the future.

Bijay Kumar, Rhode Island’s CIO added that he was “excited to see the possibilities regarding the ways in which this technology is helping public and private entities become more innovative in security, business and other areas.”

Developing new technologies to track cannabis sales has taken on an increasing level of urgency given that financial institutions are reluctant to work with marijuana businesses for fear that the federal government will take enforcement action against them. A reliable tracking system can provide assurance that only state-legal marijuana is passing through the system, and this can provide a basis for banks and other institutions to defend themselves.

Jared Moffat, Marijuana Policy Project’s political director in Rhode Island, welcomed the move by the state government to explore new ways to make the medical cannabis program more efficient.

While the notice doesn’t make any reference to medical marijuana banking, Rhode Island seems interested in using the encryption of the blockchain technology system to track the transactions which take place within the industry. This will provide a trail for regulators to confirm that the companies are paying the requisite taxes and no marijuana from licensed growers is leaking out to the black market.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) and Net Element Inc. (NASDAQ: NETE) commend Rhode Island for being forward-looking and seeking to deploy blockchain technology in the nascent medical marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The governors of 12 states across the U.S. penned a letter to leaders in Congress on Monday (June 3) urging Congress to pass bipartisan legislation which will make it possible for states to pass their own marijuana laws and implement them without any fear that the federal government will interfere in their jurisdictions.

In their letter, the Democratic and Republican governors noted that the majority of the states in the country have taken steps to legalize marijuana either for recreational or medical use. The governors also stated that state legislators had gone to great lengths to draft and pass regulations which would protect consumers, eliminate illegal marijuana sales, promote public safety and regulate the nascent marijuana industry.

Despite those great lengths to which states have gone to ensure that the emerging cannabis industry grows in a responsible way, those states only have Congressional funding riders as safeguards against federal interference in the marijuana industry. Such riders aren’t sufficient, and the governors want Congress to codify those protections into law.

The governors make specific reference to the STATES (Strengthening the Tenth Amendment Through Entrusting States) Act. The governors describe this bipartisan bill as a logical step for the federal government to take since the bill would protect marijuana businesses which are operating in accordance with state law.

They also write that the STATES Act doesn’t seek to take sides regarding whether cannabis should or shouldn’t be legal. The Act simply recognizes that states have a right to pass and implement laws which respond to the needs of their people.

In short, the governors write that the STATES Act would make the federal government a partner of the constituent states which make up the union instead of being an impediment. The governors would wish to see the federal government constantly seeking to be a partner of the different states.

The governors of Colorado, California, Maryland, North Dakota, Massachusetts, New York, Nevada, Utah, Oregon, Pennsylvania, Vermont and Washington State signed the letter.

This letter is similar to another which was also signed by 12 governors. The version sent last year didn’t have Vermont and Utah as signees but it included New Jersey and Alaska (whose governors didn’t sign this latest letter).

The letter from the bipartisan governors adds to the long list of groups which have written to Congress calling for federal marijuana law reform. The other groups include the association of banking institutions, the association of cities and local authorities as well as attorneys general.

For how long will the federal government remain impervious to all these calls? Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) and MustGrow Biologics Corp. hope it doesn’t take much longer than it already has for the federal government to listen and act upon the voices calling for cannabis law reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

On Tuesday, HempFusion, a leading U.S. hemp-based CBD company with distribution to over 3,400 retailers and an expanding product catalog, announced its engagement of RADD Capital, a partner of NetworkNewsWire, for advisory services related to its 2019 private funding initiative of more than $30 million. HempFusion co-founder and President Jason Mitchell noted in the release that the capital raised through the initiative is expected to be “a key building block to (HempFusion’s) planned growth and help accelerate (its) expansion throughout the United States and global markets including Europe, Asia, Australia, Canada, the Middle East and South America.” HempFusion is currently targeting over 26,000 new retail outlets, including conventional grocers, drug and convenience stores, vitamin and fitness shops and doctor and practitioner networks, in a global CBD industry that’s forecast by Brightfield Group to reach $22 billion by 2022.

Per the company’s website, HempFusion has been credited with creating a new category with the introduction of hemp-based nutritional supplements. Its product line is all natural, plant-based and predicated on the “amazing health benefits of (the company’s) proprietary Whole Food Hemp Complex derived from full-spectrum nutritional hemp as well as other botanicals and naturally occurring dietary hemp phytocompounds.”

To view the full press release, visit http://cnw.fm/F9IoL

About HempFusion

HempFusion is a Life Sciences company engaged in advancements of the therapeutic benefits of hemp-based CBD products, through research, collaboration, sourcing, innovation, extraction, developing and marketing of products targeting Endocannabinoid System support. The Company’s primary focus is formulating and marketing consumer-specific product lines across multiple channels and distribution platforms. For more information, visit the company’s website at www.HempFusion.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

MjMicro Conference (www.MjMicro.com) will kick off at the Westin Grand Central in New York City on June 25, 2019, with key sessions to stir cannabis industry excitement. The initial lineup for the event will feature keynote presentations by Canopy Growth Corp., Sadis Goldberg, Acreage Holdings Inc. and Virdian Capital Advisors. “MjMicro will kick off with very intentional and specific sessions prior to the core corporate presentations from 21 exciting publicly traded opportunities,” George Jage, president and COO of MjLink.com and producer of MjMicro, stated in a news release. “When designing a well-run conference, it is key to include content that creates excitement, provides clarity and validates the growth potential of the cannabis industry.”

To view the full press release, visit http://cnw.fm/xmFF1

About MjLink.com Inc.

Social Life Network, a cloud-based social media and social network technology company based in Denver, Colorado, announced on Sept. 25, 2018, the Company had spun its cannabis technology division out of the parent company and incorporated MjLink.com Inc., a Delaware Corporation, as its wholly owned subsidiary. MjLink operates as a multinational cannabis technology and media organization with two separate social networks: WeedLife.com, a consumer-to-consumer network and MjLink.com, a business-to-business social network. On April 4, 2019, the president of MjLink, George Jage, announced the launch of a new division of the company that is focused on providing the industry with best-in-class financial, B2B and B2C cannabis centric events that complement these global social networks. For more information, visit the event’s website at www.MjMicro.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: As the hemp and CBD markets grow, a wide variety of CBD- and hemp-based products are becoming available, including products for pets.

Geyser Brands Inc. (TSX.V: GYSR) (GYSR Profile) has recently announced an acquisition that provides the company with two brands of hemp and CBD products. Indiva Ltd. (TSX.V: NDVA) (OTCQX: NDVAF), which provides infused products for humans, is working on a new extraction facility to increase its production. Viridium Pacific Group (TSX.V: VIR) (OTCQB: VIRFF) is supporting the growth of the hemp and cannabis industries through investment, both in acquisitions and in partnership with smaller companies. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) has raised the public profile of CBD through celebrity associations and entry into prestige shops. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is producing CBD products for both…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

On May 28 this year, the French Senate passed a bill paving the way for marijuana to start being used therapeutically in the country. The health ministry is yet to give its approval to this law, but once it does, an experiment lasting two years will be launched to analyze the effects of marijuana on pain relief.

Patient groups put the estimate of people who would be eligible to access marijuana for pain at about 300,000-1,000,000 people. A committee is evaluating the measures which have been designed to implement the medical cannabis experiment. This committee will release their findings on June 26.

The experiment is likely to get underway in a few weeks, but the biggest challenge which will be faced is how to set up a supply chain for the industry. Initially, medical cannabis will be imported from countries where it is legal and produced to internationally acceptable standards.

As medical cannabis is imported, locally licensed producers will be busy at work setting up cultivation facilities in greenhouses or highly controlled fields. The sunlight, humidity and temperature will all be closely monitored and controlled in this unconventional agricultural undertaking.

The growers selected will be required to meet the EU rules on how to grow medical cannabis whose quality is consistent.

Medical marijuana will not be a bonanza for all who wish to use it. Physicians will only prescribe it if a patient hasn’t benefited from all the available pain treatments in the country. Of special interest will be people suffering from cancer, multiple sclerosis, some forms of epilepsy and patients undergoing palliative care.

When addressing the French Senate at the beginning of the debate on the medical marijuana bill, Senator Esther Benbassa revealed that the list of conditions for which medical marijuana could be prescribed is likely to be expanded in future to include more ailments.

Some senators, especially those from the Republican Party, fear that the medical marijuana program is being used as a Trojan horse in a bid to legalize recreational marijuana. Advocates disagree and assert that medical marijuana cannot be abused for recreational purposes since the two uses require different forms of cannabis. For example, the advocates say that therapeutic-grade marijuana is low in THC, so recreational users cannot get the psychoactive effects which they require to address their needs.

Marijuana advocates welcomed the new bill and hope that the way will be opened for exploring other purposes for which marijuana can be used. These include wellness products like supplements, oils and cannabis-infused vitamins.

Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) welcome France into the fold of countries which are benefiting from the medicinal effects of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The skyrocketing number of patients on the Canadian medical cannabis program is outstripping the capacity of the health system and the product supply to handle that surge in patient numbers, according to doctors who participate in the program.

One year ago, 250,000 patients were enrolled on the medical cannabis program. By the end of December 2018, the number had ballooned to 350,000. Current estimates put the number of patients in the program at more than 400,000. This surge is partially attributed to the legalization of recreational marijuana because this removed the stigma associated with cannabis.

However, this change in cannabis law has created challenges for physicians who prescribe medical marijuana, according to Dr. Sana-Ara Ahmed (a chronic pain specialist). According to Dr. Ahmed, many people no longer view marijuana as a medicine ever since it became available for recreational use.

During a cannabis summit in Calgary last week, Dr. Ahmed revealed that the number of patients registered to use medical marijuana is expected to hit a million by 2025. While patients have been enthusiastic about the program, the same cannot be said about physicians with just 5 percent of them prescribing medical marijuana.

Ahmed added that he is bothered by that discrepancy between the patient number and the number of physicians available to attend to those patients. He would wish to see more physicians understanding the cannabinoid system in the human body and how that system interacts with marijuana.

This discussion has been stifled by the decades of prohibition, and the hangover of that era still lingers. To compound matters, the ongoing shortage of marijuana on the legal market has also affected the medical side and doctors have to deal with the frustration of knowing that the best products, such as dried marijuana flower and CBD oil, aren’t available and yet that’s what would give patients the best results.

Dr. Ahmed also says the supply shortage isn’t all the doctors have to deal with. Many times, they are compelled to prescribe less medical marijuana than a patient requires simply because the cost of the right amount of cannabis is prohibitive for many of those patients. He cites the example of the patients who aren’t working and rely on disability support.

The black market appears to have stepped up to address some of those gaps. One operator of an illegal cannabis operation revealed that he has been serving patients in Calgary who cannot get what they need from the licensed dispensaries. He even works out arrangements to help those who cannot afford to pay for the medical marijuana that they need.

Hemptown USA and Green Hygienics Holdings Inc. (OTCQB: GRYN) hope that the Canadian government does more to address the bottlenecks preventing the medical cannabis program from serving patients fully.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

On Friday (May 31), the legislature in Alabama passed a bill which opens the way for legalizing medical marijuana in the state. The Assembly voted 80-19 for the bill while the Senate approved the amendments made by the House by a 27-2 vote. All that is left is for Gov. Ivey to sign the bill into law.

While this bill can be lauded as a step in the right direction, it also comes as a setback for marijuana advocates because the original bill sponsored by Sen. Melson (R-Florence) sought to legalize medical cannabis by 2021 but the version passed by the Assembly and sent back to Senate opted for the creation of a Medical Marijuana Study Commission which will be charged with conducting meetings and compiling recommendations about the best way to kickstart the medical marijuana program.

The proposed commission will include a minimum of three attorneys, four physicians, business representatives and mental health counselors. This commission will hold at least three public hearings and have their report ready by Dec. 1.

For some unknown reason, the findings or recommendations of the commission will not be binding on the legislature regardless of the fact that early in May, the Senate had voted in favor of implementing a medical marijuana program. The framers of the bill probably felt that the legislature needs to have the ability to formulate an implementation law, if that step is ever reached, without having its hands tied by the binding recommendations of the medical marijuana commission.

When House members posed endless questions about the mechanisms through which the medical marijuana law will be enforced and how dosages would be controlled, the sponsors of the legislation decided to switch to the creation of a commission so that all those issues would be explored comprehensively before the matter comes before the Assembly again.

Other questions raised had to do with why Carley’s law was included in this bill instead of separating it. Under Carley’s law passed in 2914, the University of Alabama was authorized and funded to conduct research on the effects of CBD oil. Legislators wanted to know whether the commission would receive input from Alabama University, and they wondered why no report has yet been provided to the House regarding how the funds appropriated for the research have been used and the findings so far made. Carley’s law was renewed for another year despite these protests.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Geyser Brands Inc. (TSX.V: GYSR) welcome the cautious approach to medical marijuana legalization taken by the Alabama legislature. Hopefully, this approach will enable the state to sidestep any avoidable mistakes during the eventual implementation of the program.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Illinois Senate passed a bill legalizing recreational marijuana and left the Assembly with just two days to approve the changes made to HB 1438 before the current legislative session ends. The House did just that on Friday (May 31), and what is left is for the governor to sign that bill into law so that the state becomes the 11^th across the country to fully legalize marijuana.

Gov. Pritzker campaigned on a platform of marijuana legalization, so he is widely expected to sign off on the bill when it gets to his desk.

If the bill becomes law, adults in Illinois aged 21 or older will be allowed to possess up to 30 grams of cannabis and the patients who are registered on the state’s medical cannabis program will now have the liberty to grow a limited number of plants for their own use. Recreational users will not be allowed to grow marijuana.

Nonresidents of Illinois will also be allowed to possess a maximum of 15 grams of marijuana without any risk that they will be prosecuted.

Rep. Kelly Cassidy, who sponsored the bill, was visibly elated and cheered as the votes came in during a session to pass the bill. The final count was 66-47, and supporters erupted into loud celebration once it was announced that the bill had passed, just in time before the end of the legislative session.

Cassidy remarked that Illinois had taken a big step towards setting the gold standard for a regulated marijuana industry which is based on equity and repair (of the harms done during the war on drugs).

This bill couldn’t have passed at a better time because the state is currently cash-strapped. The tax revenue from the regulated industry is expected to go a long way towards improving the fiscal position of the state. Currently, the pension programs of the state are short by approximately $134 billion, and the state has unpaid bills totaling $7 billion as a result of the persistent budgetary shortfalls.

During his campaign, Pritzker is on record saying that a regulated marijuana industry has the potential of adding $1 billion in tax revenue to the state each year, and the law enforcement agencies would be free to focus on other serious crimes instead of spreading themselves thin going after people who use marijuana.

However, not everyone is as positive as the governor regarding marijuana legalization. For example, Rep. Anthony DeLucas (D-Chicago Heights) regrets the passing of the bill saying that it is taking the state in the wrong direction. Earth Science Tech Inc. (OTCQB: ETST) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) are certain that time will disprove the fears of Anthony DeLucas and all those who think like him regarding a legalized marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

One of the best ways to learn about any subject of interest is by seeking out materials, such as documentaries, sitcoms, movies and other shows. This article summarizes some of the most acclaimed documentaries which will help you to delve into the different aspects (on both sides of the divide) of the cannabis industry.

Documentary #1: Weed the People (2018)

You are likely to watch this documentary with rapt attention for the entire 97 minutes that it runs. The documentary will evoke your emotions and overwhelm you as you follow the story of a group of parents and their kids suffering from cancer. You will feel the frustration of these parents as the pace at which cannabis laws change is too slow at this time when lives are at stake. You will experience the hope and relief as the parents resolve to break the law and try cannabis treatments for their kids, and you will experience the elation that the parents feel when cannabis treatments produce visible changes in the very sick kids.

Documentary #2: 420: The Documentary (2013)

In brief, 420: The Documentary primarily tells the story of how negative propaganda was used to malign marijuana, thereby resulting in the criminalization of a plant which would have benefited lots of people.

In this documentary, you will see footage from a lot of 420 civil disobedience events from around the world, and you will follow the stories of young people who had to endure prison (and even gunshots) because of their desire to consume marijuana.

There are testimonies of law enforcement officers who now regret taking part in enforcing the misguided anti-marijuana laws. Watch this documentary and learn how propaganda warped people’s views about cannabis.

Documentary #3: American Drug War 2: Cannabis Destiny (2013)

This documentary clearly brings out the fact that the biggest victims of the war on drugs are kids. The documentary follows a 2-year old kid during his battle with brain cancer. This little child is subjected to everything that conventional medicine has to offer from surgery to chemo and radiation. Nothing helps, and the parents are told to expect the worst.

Out of desperation, the parents take matters into their own hands and start researching alternative treatments for cancer. As luck would have it, they learn about an ancient treatment made from marijuana and they start injecting this concoction into the feeding tube of their son without letting the doctors in on their secret. The doctors are amazed by the “miraculous” transformation in the condition of the boy. This documentary will open your eyes to the therapeutic benefits of cannabis.

Documentary #4: Lynching Charlie Lynch (2011)

If you can now walk into a medical cannabis dispensary and buy anything you need for you symptoms, look up at the heavens and thank people like Charlie Lynch for taking the heat and pioneering medical cannabis treatments in our modern world.

The documentary shows what happened from 2006 when Charlie Lynch opened his medical cannabis dispensary in California. He followed all legal requirements of the state and was even admitted to the chamber of commerce.

However, the DEA didn’t give a hoot about all the steps he went through to abide by the existing state laws, and they raided his dispensary on numerous occasions. Eventually, he was arrested on several charges including selling marijuana to minors. In the blink of an eye, this highly respected member of the medical community acquired the label of a drug dealer. Watch this documentary and learn the hell that the early believers in medical cannabis went through.

The four documentaries above are presented in no particular order of precedence, and each will add something to your understanding of this often-polarizing subject of marijuana. Do you think any pivotal documentary was omitted? ChineseInvestors.com Inc. (OTCQB: CIIX) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) hope that such documentaries will tell the true story of marijuana and people can form their own opinions instead of relying on the untruths which are often spread far and wide about cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Canopy Growth, one of the largest marijuana companies in Canada, has teamed up with two drugs awareness organizations to develop digital tools which will help to curb drug abuse among young people.

The two entities with which Canopy Growth has partnered are Canadian Students for Sensible Drug Policy and the second is Parent Action on Drugs. The collaboration has resulted in the creation of a text messaging service and an educational chatbot which will help parents, educators and youth to speak candidly about marijuana use.

Hilary Black, the Chief Advocacy Officer of Canopy Growth, revealed that the partnership was cemented two years ago at a time when recreational marijuana was not yet legal in Canada. The partnership was born out of the realization that once recreational cannabis was legalized, concerns and questions about the likelihood of minors abusing the drug would arise.

Black added that Canopy Growth has a responsibility to make sure that kids aren’t consuming cannabis and exposing themselves to the potential risks associated with underage consumption of the substance.

Canopy Growth therefore gave one grant to Dr. Jenna Valleriani. Valleriani serves as the strategic adviser for Canadian Students for Sensible Drug Policy. That grant was used to design the educational materials contained in the Sensible Education Toolkit. The toolkit has evidence-based marijuana education guidelines designed for young people.

Parent Action on Drugs received the other grant and they used the funds to develop a chatbot and message system to convey the educational information in the toolkit to the youth.

The chatbot can be accessed on the website of Parent Actin on Drugs. It provides an interactive experience through which parents and their kids can start a frank discussion about marijuana use.

Three types of activities are available once you start the chatbot. First, you can play a game of charades and if you identify the term provided correctly, the bot gives you a number of useful tips about marijuana use.

You can also opt for the Q&A activity on the chatbot. Here, you ask questions about cannabis use and the chatbot provides the answers. The third option is titled “Scenarios” in which different real-life situations of exposure to cannabis are raised and a discussion about what one would do in those situations begins.

One has to visit the Parent Action on Drugs website in order to sign up for the SMS service. The automated texts are sent to your phone once each day for a total of 54 days. The content of the messages varies from cannabis laws, effects of cannabis on the body, to suggestions of how one can reduce or quit cannabis use if they have already taken up the habit.

The “What’s with Weed?” campaign was launched on Tuesday (May 28) and it is expected to be a major hit due to its highly interactive design. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) salute Canopy Growth for making a contribution towards equipping youth with the information they need to make informed decisions about cannabis use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative.

This seems possible when one considers the truly innovative work being done in the sector by the likes of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile), which has developed a patented delivery technology with disruptive potential, delivering 475% more CBD to the bloodstream after 15 minutes than conventional formulations. Other sector innovators are making a similar impact, including the likes of noted cannabinoid biopharma GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) and that of researchers and product developers Tilray Inc. (NASDAQ: TLRY), MariMed Inc. (OTCQB: MRMD)and Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB).

To view the full editorial, visit http://cnw.fm/sd82F

To hear the CannabisNewsAudio version, visit http://cnw.fm/xJB7q

About Lexaria Bioscience Corp.

Lexaria Bioscience has developed and out-licenses its disruptive delivery technology, which promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the United States and Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates, more rapid delivery to the bloodstream, and important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

In a 7-0 emphatic decision, the Supreme Court of Arizona has quashed a ruling by the Court of Appeal to the effect that marijuana concentrates, such as hashish, were not included in the law which legalized medical marijuana in the state.

This case arose after Yavapai County convicted a patient with a valid medical marijuana card issued by the state for possessing hashish. In their ruling delivered on Tuesday (May 28), the justices affirmed that the law legalized all forms of the cannabis plant, including the concentrates made from any segments of the plant that manufacturers deemed fit for processing.

For over a year, the decision of the Court of Appeal had stood and restricted the potentially explosive growth of the cannabis concentrates industry since the court ruling had excluded concentrates from the products envisaged by the 2010 law.

The cannabis extracts sold in medical marijuana dispensaries across the state include soda, candy, vape pens, food and many other products. Records show that the sale of cannabis concentrates is growing at a faster pace when compared to marijuana flower. For example, in the year ending April 2019, sales of cannabis flower grew by 33 percent while sales of concentrates surged by 71 percent in the same period. The 71 percent growth doesn’t include cannabis edibles.

It would therefore have been damaging (and strange) if the highest court has upheld the decision of the lower court. Many jurisdictions where medical marijuana is legal only allow extracts, such as cannabis oil, tinctures, creams, gels and ointments. These include Pennsylvania which only accepted smokable cannabis recently.

It is noteworthy that the dispensaries and manufacturers, such as Item 9 Labs, only paused cannabis concentrate sales briefly after the Court of Appeal ruling and then continued business as usual after their legal teams advised them that there was no legal basis for banning the concentrates.

The legal counsel of those companies has now been vindicated after the Supreme Court pronounced itself on the matter.

Patients have welcomed the latest ruling since the decision ensures that they will continue accessing marijuana concentrates. Many of the patients on the medical marijuana program are either unable or unwilling to smoke medical marijuana. Concentrates also provide a precise way to determine the dosage consumed, an attribute which is vital if the desired therapeutic effects are to be attained.

Lindsey Bartels, a patient who lives in Tempe and has battled chronic pain for years, admitted as much when she said cannabis oil allows her to live a normal life. Youngevity International Inc. (NASDAQ: YGYI), Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and the entire cannabis industry welcomes the court decision in Arizona which has given patients like Lindsey Bartels hope that they will continue having access to cannabis concentrates which have proved immensely helpful in improving the quality of their lives.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the legislative session enters its final days, the senate in Illinois has voted to pass a recreational cannabis legalization bill after months of debate and modification. The bill now goes to the Assembly before being presented to Gov. Pritzker by the end of this month.

The bill has a number of provisions which are intended to promote social equity once the marijuana industry becomes fully legal. For example, the bill provides for the automatic expungement of previous convictions for the possession of less than an ounce (30 grams) of marijuana. Individuals who were convicted for possessing between 30-500 grams of marijuana can appeal to court for expungement, or the state’s attorney can petition court on behalf of those individuals.

One notable change which was made to the original bill regards the home cultivation of recreational marijuana. While the original bill provided for the home cultivation of up to five plants, the revised version changed that provision and only allowed patients on the medical marijuana program to grow up to five plants. The law under which medical marijuana became legal didn’t allow home grows.

The bill also decriminalizes low-level marijuana cultivation (five or fewer plants) by non-patients. This means that those found growing few plants will be fined up to $200 instead of serving a custodial sentence upon conviction.

The bill stipulates the taxes which different recreational marijuana products will attract. Cannabis flower whose THC content is less than 35 percent will attract a 10 percent tax while any cannabis products with more than 35 percent THC content will attract a 25 percent tax. Marijuana-infused drinks will face a 20 percent tax. The state will also impose an additional 6.5 percent sales tax, and local authorities will be free to impose an extra 3.5 percent tax on recreational marijuana products.

Under the bill, individuals who have convictions that qualify for expungement and those who live in areas described as disproportionately affected by the war on drugs qualify to be categorized as equity applicants as business license applications are considered. Such equity applicants qualify for extra points during the scoring process and they are also eligible for fee waivers.

Social equity applicants can also obtain a low-interest loan from a special $30 million fund created by this law to help such applicants to meet some of the costs associated with starting a marijuana business.

Sen. Heather Steans, the sponsor of the bill, described the proposed law as one which will set the gold standard for creating a cannabis industry which embraces diversity.

If the bill becomes law as planned, it will take effect on the first day of 2020. Dispensaries would receive licenses by May 1, 2020 while transporters, craft growers and processors would get their licenses by July 1.

Advocates have welcomed this bill saying that while it isn’t perfect, it is better than having prohibition extended for longer. What is now left is for the Assembly to consider and pass the bill so that it gets to the desk of the governor in time. VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) hope that nothing happens to derail the long-awaited legalization of recreational cannabis in Illinois.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Cannabis companies are using increasingly refined acquisition tactics to create vertical integration.

TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) has developed a refined acquisition strategy, assessing more than one hundred targets before settling on a select few to acquire. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of America’s leading multistate cannabis companies, has recently announced its agreement to acquire CannaRoyalty Corp. (OTCQX: ORHOF), giving it control over a vast distribution platform. In Canada, HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has been given approval to acquire Newstrike, as the country’s vibrant industry consolidates following recent dramatic growth. For those without vertical integration, companies such as DionyMed Brands Inc. (CSE: DYME) (OTCQB: DYMEF) provide vital support services, including logistics and distribution.

To view the full editorial, visit http://cnw.fm/HyOr5

To hear the CannabisNewsAudio version, visit http://cnw.fm/6OdMP

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://cnw.fm/TCAN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Growing demand for CBD is increasing pressure on companies that provide key cultivation equipment and industry supplies.

As part of its commitment to build a large and well-supplied sales channel, hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is in the process of making acquisition of companies that supply the hemp industry. An increasing need for supplies is coming from companies such as Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), a major cultivator and processor making moves on the CBD drinks and well-being markets. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) has entered into a supply agreement with another provider to ensure the materials it needs for its products. Global efforts by companies such as New Age Beverages Corporation (NASDAQ: NBEV) and Aphria (TSX: APHA) (NYSE: APHA) may further strain U.S. supply chains, due to greater cultivation restrictions in other parts of the world.

To view the full editorial, visit http://cnw.fm/i26Li

To hear the CannabisNewsAudio version, visit http://cnw.fm/VPt1M

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include Zenhydro.com, AthenaUnited.com, CarryOutSupplies.com and BudLife Cannabis Storage Solutions. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

With its 6th Annual Cannabis Business Summit & Expo, the National Cannabis Industry Association (NCIA), the largest cannabis trade association in the U.S. and the only organization broadly representing state-sanctioned cannabis-related businesses at the federal level, is once again offering a unique opportunity to intermingle with industry innovators and influencers. Set to run from Monday, July 22, to Wednesday, July 24, at the San Jose Convention Center, the event will feature presentations by 150+ influential figures. Over 10,000 attendees are expected. They will be served an informative fare that includes updates on current developments in the space, as well as insightful projections regarding the forces that may shape the industry in the future.

On the rostrum this year will be Michael Cooper, co-founder and managing member of MadisonJay Solutions, considered the leading consultant on regulations in the adult-use cannabis sector. He will be joined by Lisa Hansen, vice president of Plaid Marketing, a company out to democratize financial services through…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Voters in Missouri approved a ballot measure which legalized medical marijuana in 2018. In March this year, the Department of Health and Senior Services released draft rules for the medical marijuana program and invited public comment on those rules. Last week, the department completed making changes to the draft rules based on the feedback received and they published the revised draft rules on the department’s website on Friday.

The rules cover 11 broad aspects of the medical cannabis program. These include rules covering patients and caregivers participating in the program, cultivation facility license procedures and requirements, testing facilities, seed to sale marijuana tracking and the rules governing medical marijuana manufacturing facilities.

The Department of Health and Senior Services (DHSS) will start receiving patient applications based on these rules on July 4 while applications from businesses which want licenses will be received starting August 3. The application forms are now available on the website and all interested parties can access and fill those forms.

DHSS will then start scoring the business applications and complete this exercise on December 31 this year, after which business licenses will be issued to the successful applicants in 2020.

The medical marijuana program has attracted a lot of interest from the business community, and the state expects to generate millions of dollars in taxes and fees from the industry.

However, the actual earnings are likely to fall short of what has been predicted. Economics professors at Missouri University crunched the numbers and concluded that the number of eligible patients in the state would be less than initially expected. The professors estimated that in 2022, the medical marijuana program is likely to raise about $3.4 million in taxes and fees, a figure which is much lower than the $24 million predicted by the people behind the initiative which saw the approval of the ballot measure legalizing medical marijuana.

In the meantime, 510 applications have been pre-filled and are due to be submitted. Those applications have generated more than $3.67 million in application fees. From these applications, 60 cultivation facilities, 86 manufacturing facilities and 192 medical marijuana dispensaries will be selected. The state will license 24 dispensaries for each of the eight congressional districts.

These draft rules will also be subject to public comment and a public hearing will be organized in July. TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) applaud the authorities in Missouri for systematically implementing the roadmap to the commercialization of the medical marijuana program.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Transportation Security Agency (TSA) has updated its website to show that a pediatric epilepsy drug made from marijuana can now be accepted on flights. This change comes after the TSA was notified about the approval of that drug by the Food and Drug Administration (FDA).

The updated guidance provided to passengers by the TSA indicates that subject to special conditions, certain forms of medical marijuana can now be taken on board flights either in checked luggage or carry-on luggage.

The government agency added that while the federal government’s position on substances containing marijuana hasn’t changed, an exception is being made for the CBD-infused drug which has received FDA approval for the treatment of severe forms of epilepsy in kids.

The TSA revealed that this new change is likely to catch many of its agents unaware, so efforts are being made to brief them on the matter.

The officials from the TSA stated that the agency is primarily interested in matters of security rather than searching for illegal substances. However, in the conduct of their duties, they often come across illegal substances, such as marijuana. In such a case, the matter is brought to the attention of law enforcement agencies for appropriate action.

The new guidance published on the TSA website brings a sigh of relief to many parents who were unsure whether they would be breaking the law if they travelled with this cannabis-derived drug with or without their epileptic kids.

The clarification should not be stretched by travelers to mean that medical marijuana is now allowed on flights. Marijuana remains a Schedule 1 substance under U.S. federal law, so you risk being arrested and prosecuted if you attempt to bring your medical cannabis on any flight. Only the FDA-approved drug has been given an exception to the rule that marijuana and products containing it aren’t allowed on flights.

Cannabis industry advocates have welcomed this updated TSA guidance because, to them, it is common sense that once the drug became legal then it couldn’t be on a list of restricted items which aren’t allowed on flights.

The advocates feel that the federal governments and its agencies should also think about states where marijuana is legal in some form, whether for medical or recreational use. The federal government should pass legislation recognizing that those states are free to pass and implement their own cannabis laws without interference from the federal government. This is as logical as the TSA writing that the FDA-approved cannabis drug can now be allowed on flights.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) applaud the step taken by the TSA to clarify that families can now take the cannabis-derived epilepsy drug on flights.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative.

This seems possible when one considers the truly innovative work being done in the sector by the likes of Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile), which has developed a patented delivery technology with disruptive potential, delivering 475% more CBD to the bloodstream after 15 minutes than conventional formulations. Other sector innovators are making a similar impact, including the likes of noted cannabinoid biopharma GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF) and that of researchers and product developers…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

A Spanish company, Hemp Trading, has developed a new cannabis strain that has no THC. This development became possible after the company partnered with UPV (Universitat Politecnica de Valencia) university in Spain. The new cannabis plant is expected to have numerous therapeutic benefits.

This first-of-a-kind marijuana strain has no legal restrictions imposed upon it since it doesn’t contain any controlled ingredient in it, especially the psychoactive THC which is responsible for the controlled substance status of marijuana around the world.

Ernesto Liosa, the CEO of Hemp Trading, reveals that the company developed this unique cannabis strain by blocking some of the steps through which the biosynthesis of cannabinoids takes place as a cannabis plant grows.

The company’s scientists managed to block the formation of THC while increasing the quantity of cannabigerol (CBG). CBG has several possible medicinal effects. The researchers discovered that CBG is the first cannabinoid of cannabis to form. Consequently, CBG can be regarded as the “mother cell of marijuana” because as the plant grows, CBG is transformed into the two major known cannabinoids (CBD and THC) as well as the other dozens of cannabinoids present in cannabis. This conversion causes CBG to disappear almost completely.

This research has therefore made it possible for the levels of CBG in cannabis to be elevated to concentrations which were unheard of. The other strains of marijuana on the market have concentrations of CBG which range between 0.1 percent and 0.5 percent. The strain developed by Hemp Trading raises the CBG concentration to 15 percent.

The minute quantity of CBG in the current cannabis plants meant that hardly any research was done on this cannabinoid by the scientific community. Most attention went to CBD and THC since these occur in large amounts in most cannabis plants.

Now that CBG has been boosted to 15 percent, the way has been opened for the scientific community to look into the potential therapeutic uses of this cannabinoid.

CBG holds great promise because it is easier to extract when compared to how CBD is extracted from the existing strains of marijuana. The extracts have to be purified to get rid of the THC content. Even hemp which is known for its low THC level must also undergo this purification process in order to eliminate those trace amounts of THC.

The strain developed by UPV and Hemp Trading will be more affordable to process in order to extract the CBG since there is no THC in the plant. The savings made during this extraction process are certain to make the products more competitive on the market.

So far, CBG has been linked to fighting inflammation, reducing intraocular pressure (thereby showing promise in fighting glaucoma), fighting insomnia and depression. More research is likely to unearth additional therapeutic benefits.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) and Sugarmade Inc. (OTCQB: SGMD) congratulate Hemp Trading and UPV upon their groundbreaking research which will take the medical cannabis sector to another level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

While medical marijuana is legal in Australia, many patients are finding it difficult to find physicians who are willing to prescribe the substance. This has forced those patients to resort to illicit sources of medical marijuana in order to alleviate their symptoms.

Qualifying patients, such as Trembath Forster who lives in Canberra, say that they have to travel hundreds of miles to access a doctor who is licensed and willing to prescribe medical marijuana. Such trips are not only financially strenuous but also nearly impossible for patients with mobility challenges.

Trembath Forster reveals that she and other patients have encountered ignorance and outright arrogance when they approached many local doctors about a prescription for medical marijuana. Such doctors have no qualms about putting the patients on any strong opioids or prescription medications available, but they become hostile or evasive when the subject of medical cannabis is raised.

Australian law imposes stringent conditions which must be met before a patient can use medical marijuana. First, the patient must find a doctor who has been licensed to prescribe “unapproved therapeutic goods.”

For a physician to get such a license, he or she must have undergone extensive training and acquired expertise in the condition/disease from which the patient is suffering. The physician should also have undergone training on how to use the “unapproved therapeutic goods” to treat the specific condition for which the patient is seeking medical marijuana as a remedy.

The licensed physician is also expected to monitor the condition of the patient while that patient is using medical marijuana. In other words, the physician is responsible for what happens to the patient as a result of that patient’s consumption of medical marijuana.

Benjamin Graham, the Executive Director of a non-profit called Chronic Pain Australia, explains that those stringent conditions could be to blame for the brick wall patients run into when they talk to their GP about medical marijuana. In Trembath Forster’s case, her GP was sympathetic but lacked the license to prescribe medical marijuana.

Graham added that most patients his organization interacts with say that their GPs are either ignorant about medical marijuana or they are biased against the treatment option. He has hope that as more patients request for medical marijuana, more doctors will undergo the needed training in order to get the license from the Therapeutic Goods Administration of the Australian government’s Department of Health.

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) hope that the authorities in Australia come to the aid of the patients and conduct campaigns to register more physicians on the medical marijuana program. This will make it easier for the patients who desperately need medical marijuana to get a prescription for it.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Cannabis companies are using increasingly refined acquisition tactics to create vertical integration.

TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) has developed a refined acquisition strategy, assessing more than one hundred targets before settling on a select few to acquire. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), one of America’s leading multistate cannabis companies, has recently announced its agreement to acquire CannaRoyalty Corp. (OTCQX: ORHOF), giving it control over a vast distribution platform. In Canada, HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) has been given approval to acquire Newstrike, as the country’s vibrant industry consolidates following recent dramatic growth. For those without vertical integration, companies such as DionyMed Brands Inc. (CSE: DYME) (OTCQB: DYMEF) provide vital support services, including…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: Growing demand for CBD is increasing pressure on companies that provide key cultivation equipment and industry supplies.

As part of its commitment to build a large and well-supplied sales channel, hydroponic supplier Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is in the process of making acquisition of companies that supply the hemp industry. An increasing need for supplies is coming from companies such as Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), a major cultivator and processor making moves on the CBD drinks and well-being markets. Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) has entered into a supply agreement with another provider to ensure the materials it needs for its products. Global efforts by companies such as New Age Beverages Corporation (NASDAQ: NBEV) and Aphria (TSX: APHA) (NYSE: APHA) may further strain U.S. supply chains, due to greater…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Banking associations from all the 50 states across the U.S. have written a letter to the Senate Banking Committee to pass and advance the bipartisan bill before it seeking to protect financial institutions from federal penalties for doing business with licensed marijuana businesses.

In their letter delivered on April 20, the state banking associations observed that forcing cannabis businesses to operate on a cash-only basis exposes the businesses, their employees and the public to serious safety risks.

The banking associations also added that regulation and enforcement has been very difficult, something that can have adverse effects on the economy. Tax collection becomes inefficient and expensive since modern methods of remitting payments cannot be used. Compliance audits also become expensive because there is no clear paper trail to follow when looking into the financial records of marijuana businesses.

The banking associations also complained that while the Congressional Financial Services Committee passed a similar bill in March, other committees haven’t acted on the companion bills since then.

In their letter, the banking associations were quick to point out that they are neither in favor of nor against the legalization of marijuana. Their sole purpose is to serve the communities in their areas, including jurisdictions which have opted to legalize marijuana.

They added that there are many legitimate concerns which have to be considered on the subject of marijuana, but they were calling on Congress to narrow their focus for now on the issue of the banking sector with respect to the marijuana industry while other broader issues on marijuana policy are debated.

The Chairman of the Senate Banking Committee, Sen. Mike Crapo, revealed that he wouldn’t commit himself to bringing the marijuana banking bill before his committee until the Department of Justice had pronounced itself on the matter.

However, the banking association from the senator’s own home state seems to disagree with him and signed the letter. The association of attorneys general also disagrees and sent their own letter urging federal action to be taken to ease marijuana banking.

The National Association of State Treasurers has also written a letter calling on Congress to enact legislation which will make it possible for the cannabis industry to receive basic banking services in the states where such businesses are legal and licensed. Their reasons mirror the reasons stated by the 50 banking associations from all the states in the country.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) look forward to the day when the federal government will listen to the voices of the different associations asking for enabling laws to allow cannabis businesses to thrive in the states where they are licensed to operate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The senate in California passed a bill on Tuesday (April 21) paving the way for the creation of state-chartered banks for the cannabis industry. These banks will help the cannabis industry to get around the banking restrictions resulting from the federal status of marijuana.

Under the bill, credit unions and private banks can apply to the state for a limited purpose charter to provide depository services to legitimate marijuana businesses within the state. This bill was passed with a 35-1 vote and now awaits approval by the Assembly and Gov. Gavin Newsom.

Currently, all marijuana businesses, such as cultivators and retailers, are forced to accept only cash because federally-chartered banks are afraid to accept them as clients. California will therefore exert pressure on the federal government to consider easing its marijuana banking regulations since California is the most populous state in the nation.

Robert Hertzberg, California’s Senate Majority Leader, remarked when introducing the bill last month that while the proposed law wasn’t an ideal remedy to the dilemma facing cannabis banking, it was a good step to take along the journey of treating cannabis businesses as legitimate businesses like all others. The bill would allow money from the cannabis industry to be taken from the streets to bank accounts.

The financial institutions which get the special-purpose charters would print special checks that marijuana businesses can use to pay rent, local and state taxes as well as any other fees. The financial institutions created to work with cannabis businesses will not offer any loans to their clients, so marijuana businesses will still have to get funding using other methods.

The lack of banking services has made it very difficult for regulators and law enforcement to stamp out illegal marijuana businesses since both legitimate and black market activity is cash-based.

It isn’t clear whether financial institutions will warm up to cannabis businesses once this bill becomes law. Banking institutions are wary of working with cannabis businesses because they are exposed to enforcement action by the federal government, so it is not yet clear whether this proposed law will allay their fears.

Currently, more than 30 states have legalized medical marijuana while 10 states, plus the District of Columbia, have legalized recreational cannabis. More are considering bills or petitions to pass their own marijuana laws. The step taken by California will therefore be watched closely since other jurisdictions may follow its lead if the measure produces tangible results.

Organigram Holdings Inc. (TSX.V: OGI) (OTCQX: OGRMF) and Net Element Inc. (NASDAQ: NETE) look forward to the enactment of SB 51 so that cannabis businesses in California can access the limited banking services envisaged in that draft law.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Companies with a presence in the CBD market are seeing their profiles rise, thanks to growing media and celebrity attention.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD store. Tilray Inc. (NASDAQ: TLRY) has seen strong market coverage as its shares rose following action to tackle product shortages in Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED)has fostered its public profile through efforts by the company’s media-savvy co-CEO. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) drew attention as its share value rose with a large external investment. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) has been focusing on growing better CBD-producing plants, work that has drawn attention to its VP of cultivation.

• Kim Kardashian’s CBD-themed baby shower drew attention to the range of relaxing CBD products.
• Other high-profile appearances are boosting upper-end CBD brands.
• Broad media coverage is normalizing and drawing customers to the sector.

To view the full editorial, visit http://cnw.fm/1UkAs

To hear the CannabisNewsAudio version, visit http://cnw.fm/Fb6Bj

About Wildflower Brands

Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy, toward becoming a global wellness leader. For more information, visit the company’s website at www.WildflowerBrands.co.

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://cnw.fm/WLDFF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

As plans to legalize recreational marijuana seem to have hit a dead end, lawmakers in different New Jersey legislative committees have advanced the expansion of the medical marijuana program, marijuana criminal expungement and marijuana decriminalization bills.

On Monday afternoon (May 20), the Appropriations Committee of the Assembly debated and advanced a decriminalization bill. This bill seeks to make the possession of less than two ounces of cannabis a civil offense punishable by a $50 fine. The same committee also passed a bill to expunge marijuana convictions.

The version of this bill passed by a senate committee didn’t mention decriminalization. The intention was to include this provision at a later stage of the process after the different bills make their way through the different committees just before they are combined into one bill ready for presentation to the entire Assembly or Senate.

The Health and Human Health Services Committee of New Jersey’s senate also passed a bill to expand the state’s medical marijuana program. This bill proposes several changes to the existing law. For example, health professionals would now issue a prescription for medical cannabis for an entire year instead of just 90 days as has been the case under the current law.

The bill also allows patients to buy medical cannabis from any dispensary they choose within the state. Previously, patients could only buy medical marijuana from the dispensary where they were registered as they joined the medical marijuana program.

Patients will also be allowed to buy up to three ounces of medical cannabis at a go. The current law imposes a limit of one ounce, and this forces patients to make several trips to a medical cannabis dispensary to replenish their medical cannabis supply. This bill had earlier on been approved by the Appropriations Committee of the state Assembly.

While medical marijuana advocates see the bill to expand the medical marijuana program as imperfect, they recognize that it is far better than the existing legal framework so they will be happy to see it pass into law.

Patients and advocates were becoming increasingly frustrated by the delay to pass the expansion of the medical marijuana program even if it enjoyed universal support. The delays were intended to build consensus on the legalization of recreational marijuana, but there is a growing resignation to the possibility of putting the matter to a vote next year since lawmakers show no sign of agreeing on how full legalization should be implemented.

Steve Sweeney, the Senate President, also seems resigned to the fact that recreational cannabis is still a long way from being legalized legislatively. He revealed that while the bill to expand the medical marijuana program will soon be passed, he could not say the same for the bill to legalize recreational cannabis.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) and MustGrow Biologics Corp. hope that the bills approved by the various committees are cleared by either House quickly so that patients can enjoy better access to medical cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Canopy Rivers, one of the largest growers and suppliers of medical marijuana in the world, has invested $1.5 million in BioLumic, an agri-tech company based in New Zealand. The funds are intended to help the agri-tech company to develop UV treatments which can boost the performance and yield of marijuana plants.

Warren Bebb, the CEO of BioLumic, said that he was glad that companies from around the world were starting to pick interest in what his company is doing. Bebb attributes this interest to the results which they have already obtained for other flowering plants, such as tomatoes, soybeans, lettuce and strawberries.

The New Zealand parliament recently passed a law to give terminally ill patients a legal defense to possess and use cannabis (an illegal substance). This amendment has paved the way for companies with interests in medical cannabis to position themselves to get a share of the global medical cannabis industry which is predicted to grow to an $80 billion industry within the coming five years.

BioLumic is excited to take a shot at making a difference in the life of someone suffering from a terminal illness. The UV treatments developed by the company have already shown that performance and yield can increase by up to 40 percent. Test crops have been grown in various countries, such as Spain, Britain and Mexico.

Dr. Wargent, one of the co-founders at BioLumic, says that his company is unique because of the shorter time they need to treat plants. For example, they need just a week or two to treat seedlings and only a few minutes to treat seeds.

Once the scientists have treated the seeds or seedlings, no other treatment is required for the rest of the life of that plant.

Wargent, a photobiologist, explains that he started out by testing his revolutionary technology on just a few plants that he left within his bedroom. Last year, he and Bebb opened a state-of-the-art UV research and development facility at Massey University.

While the founders weren’t sure which exact direction their company would take, they were in agreement that it should become a unicorn (a start-up which grows to be worth at least $1 billion).

The investment by Canopy Rivers and other entities has helped BioLumic to get its journey to unicorn status underway. The funding from Canopy Rivers will also go towards expanding the Artificial Intelligence program of BioLumic in addition to upgrading security at their trial facilities around the world.

Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) congratulate BioLumic upon landing such a major client in the cannabis industry and hope that their partnership results in a method to take medical marijuana production to a new level of efficiency.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Growing media attention and celebrity acceptance is fueling rising popularity of CBD.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD salon. Aurora Cannabis Inc. (NYSE: ACB) is working with the UFC (Ultimate Fighting Championship) and its athletes in clinical studies involving pain management, inflammation, injury, exercise recovery and mental well-being. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) recently acquired Beboe, a luxury cannabis brand founded in California. With this growing CBD popularity, HEXO Corp. (NYSE American: HEXO) announced that it has become the first cannabis company to join Food & Consumer Products of Canada (FCPC), the largest voice of the Canadian food, beverage and consumer products industry. And Aphria Inc. (TSX: APHA) (NYSE: APHA) has been awarded a fifth lot for the cultivation of medical cannabis in Germany as part of the company’s previously awarded license from…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Lawmakers in Nebraska started debating a proposal to legalize medical marijuana in the state as cannabis advocates pushed to put the matter before voters next year.

Cannabis advocates are unhappy about the legalization bill because, in their view, it is too narrow and restrictive. For example, the bill bans the smoking of medical cannabis yet advocates see smoking as one of the cheapest ways for patients to get their dose of medical cannabis. Other forms require processed cannabis, which is more expensive, so medical marijuana will be out of the reach of many patients if smoking it isn’t allowed.

The activists also have serious concerns about what the bill has to say about qualifying conditions. The proposed law recommends that patients who want to use medical marijuana must have their qualifying condition certified every 90 days. This step is cumbersome and will inconvenience patients a great deal, they say.

Just having a listed qualifying condition will also not be enough to get one on the medical cannabis program. Other requirements must be met as well. For example, patients suffering from a terminal illness can only use medical marijuana if they have less than a year to live, while those with chronic pain must have had it for longer than three months without getting any improvement after taking non-opioid medications.

The debate on this bill was so polarized that the Speaker was forced to halt it barely three hours after it commenced. The sponsors of the bill, such as Sen. Anna Wishart, see no chance of the bill getting sufficient support to pass on the floor of the legislature after witnessing her colleagues spend more time talking about recreational marijuana rather than discussing the bill before them.

Supporters are now considering putting the matter before voters using a ballot measure during the elections next year. They feel that letting voters decide will result in a less restrictive law which is truly aligned with the needs of patients.

For example, the petition will include a call to allow home cultivation of medical marijuana so that patients can reduce how much they have to spend on medical cannabis products.

However, getting medical marijuana legalized through a ballot measure will not be a walk in the park as there are groups which are opposed to any form of marijuana legalization in the state. Some protestors have been describing themselves as “marijuana refugees” who fled from other states where marijuana is legal to Nebraska where the substance hasn’t been legalized either for medicinal or recreational use.

The activists will therefore have to do a lot of work to secure a majority vote if the initiate is to register success. Hemptown USA and Green Hygienics Holdings Inc. (OTCQB: GRYN) wish that the legislators had been more objective and spared the voters the lengthy process of using a ballot measure to give patients another treatment option for their conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

For those who may not know, the Emerald Cup can be described as the world championship for the outdoor cultivation of marijuana. This competition is held every year in California. This year, the Emerald Cup is debuting in Europe after the organizers teamed up with the organizers of Product Earth Expo-Fest held in the U.K each year.

The two entities announced their partnership at the start of this week and they plan to use the UK event in August to showcase what growers from the Emerald Triangle have to offer the rest of the world.

James Walton, the founder of Product Earth Expo-Fest, revealed that the partnership with the Emerald Cup was a natural result of the two entities sharing the common objective of showcasing the future of cannabis cultivation around the world.

Walton explains that he came up with the concept of the Expo-Fest after thinking deeply about how he could combine his love for music and his passion for the cannabis industry. He was therefore pleasantly surprised to learn that the Emerald Cup in California was doing exactly the same thing, hence the partnership.

Taylor Blake, the co-producer of the Emerald Cup admitted that he didn’t know that strains and brands from California were a big hit in Europe, and he was excited to learn that the Emerald Cup had played a big role in building those brands across the Atlantic.

Expanding to Europe will therefore give California cultivators a bigger stage on which to showcase their products, and this will result in a bigger footprint for those products in the global cannabis industry.

The August even will be held between the 23^rd and the 25^th of the month. The major highlights of the planned event include cannabis genetics panels which will discuss how cannabis strains have developed and continue to be developed in order to address the unique needs of different groups of consumers.

There will also be Question & Answer sessions with the best cultivators from California, workshops about cannabis production and harvest, as well as many focus groups on various aspects of the industry. And, of course, there will be plenty of music for the event attendees to enjoy as they soak up all the information that they can absorb about outdoor cannabis cultivation.

Come December this year, all eyes will be on Santa Rosa, California where this year’s edition of the Emerald Cup will be held. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Geyser Brands Inc. (TSX.V: GYSR) wish the new partnership between the Emerald Cup and Product Earth Expo-Fest many years of fruitful collaboration.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The sponsors of the first recreational cannabis bill in New York have now introduced a new bill which will replace the one that wasn’t included in the budget framework read early this year. The sponsors of this new bill are convinced that this version stands a higher chance of success because it incorporates the ideas suggested during negotiations prior to reading the budget.

Sen. Liz Krueger (D-Manhattan) says that the new bill creates a single government entity which will be responsible for regulating all the cannabis and cannabis-related products, such as hemp and CBD products.

Hemp and CBD products are included in this bill in order to remove the legal gray area since those products aren’t currently covered by any existing law. By including these products in this bill, the lawmakers want to save the time and resources which would have been used to draft and pass a separate bill for those products.

Crystal Peoples-Stokes, the Assembly Majority Leader and longstanding supporter of cannabis legalization, says that the new bill also has a social equity provision through which a portion of the tax revenue collected will be allocated for spending in communities which suffered the worst of the futile war on drugs.

Other provisions of the bill deal with expunging past criminal records, helping people from disadvantaged communities to enter the legal cannabis industry and agreeing on a taxation structure.

One major issue that was divisive was the home cultivation of marijuana. Opponents of cannabis legalization don’t want this included in any legalization law, while supporters, such as New York Mayor Bill de Blasio, insist that home cultivation should be allowed so that “Big Marijuana” doesn’t dominate the industry.

Some money will also be set aside to facilitate the police to enforce the new recreational cannabis law, while more money will be allocated to cannabis research, drug prevention and treatment.

Another compromise which is included in the new bill relates to marijuana criminal record expungement. The previous bill recommended mass expungement and this was met with stiff opposition. The revised bill suggests that only misdemeanor cannabis convictions will be expunged.

Many aspects of the medical cannabis program are also tackled in this bill. For example, the bill seeks to allow doctors to exercise their discretion in determining whether medical cannabis could be helpful for a given patient, instead of being restricted to prescribing it only for patients who suffer from one or more of the 17 qualifying conditions listed in the law in place.

The entire cannabis industry, including Earth Science Tech Inc. (OTCQB: ETST) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) hope that this new bill receives a more favorable reception so that cannabis legalization isn’t delayed any longer.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the legislative session draws to an end in Illinois, an opinion poll conducted shows that the majority of Illinoisans (60 percent) want recreational marijuana to be treated just like alcohol. This poll comes barely two weeks after another poll, sponsored by those opposed to cannabis legalization, showed that support for recreational marijuana legalization was waning.

This latest poll was sponsored by Gov. J. B. Pritzker and it was conducted by the Global Strategy Group. The pollsters asked 802 registered voters in the state whether they were in support of, or opposed to legalizing, regulating and taxing recreational marijuana in the same way as alcohol. The poll started on April 29 and ended on May 1.

In general, 60 percent of the respondents expressed their support for legalizing, taxing and regulating recreational cannabis like alcohol while 35 percent opposed it.

When the findings were broken down by location, the Chicago area showed the greatest support when compared to downstate areas.

Two weeks earlier, Mason-Dixon Polling & Strategy had been commissioned by Smart Approaches to Marijuana (an organization opposed to cannabis legalization) to conduct a poll on the views of Illinoisans towards recreational cannabis legalization.

That poll found that only 41 percent of the people in Illinois supported legalization. The poll was conducted on May 7 and 8. However, this poll came under intense criticism because of some of the questions it posed.

For example, the pollsters asked voters whether all forms of cannabis use should be made illegal. This question was criticized because medical marijuana has been legal in the state and there is no plan to alter its status in Illinois.

However, the poll conducted by the Global Strategy Group had the twist of not just asking voters about cannabis legalization but also asking them to compare recreational marijuana regulation to alcohol.

Alcohol is widely available and no limits are imposed on how much alcohol adults can buy or consume. The poll therefore wanted to find out whether recreational cannabis should also have minimal restrictions.

A lot of resources have been injected into the campaign to legalize recreational marijuana by its supporters. Opponents have also gone all out to thwart the attempts to legalize recreational cannabis.

The sponsors of the legalization bill told a senate committee that the industry is likely to bring in sales of about $500 million when the industry matures in five to six years. The bill also provides for the automatic expungement of marijuana convictions (without subjecting the affected people to a lengthy application process).

ChineseInvestors.com Inc. (OTCQB: CIIX) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) hope that Gov. Pritzker’s intention to see recreational marijuana legalized by the end of this legislative session sees the light of day.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: Companies with a presence in the CBD market are seeing their profiles rise, thanks to growing media and celebrity attention.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) (WLDFF Profile) is one of the companies benefiting most from this attention, with its products featured in Kim Kardashian’s baby shower and the new Saks CBD store. Tilray Inc. (NASDAQ: TLRY) has seen strong market coverage as its shares rose following action to tackle product shortages in Canada. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has fostered its public profile through efforts by the company’s media-savvy co-CEO. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) drew attention as its share value rose with a large external investment. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) has been focusing on growing better..

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

When Proposition 64 was passed, one of its “key” promises was that local authorities would have the right to decide whether to license recreational cannabis businesses within their jurisdictions or not. About 70 percent of all cities and counties have opted to ban recreational cannabis sales within their jurisdictions, and this has hampered the growth of the cannabis industry. Now some lawmakers are proposing that this tenet of Prop 64 be changed to rein in the power of local authorities on the matter. Several arguments have been presented in favor of and against this suggestion.

First, those in favor of Assembly Bill 1356, the bill which would force local authorities where a minimum of 50 percent of the voters supported Prop 64 to license some pot shops, say that the blanket ban on cannabis businesses has created room for the black market to thrive since locals have no access to legal marijuana.

Because of that black market activity, the state has been unable to regulate and tax those illegal cannabis sales. This creates public health safety issues. For example, the unregulated marijuana may have high concentrations of pesticides and other contaminants which can affect the health of consumers. The loss of tax revenue also denies the state the funds that it needs to deliver services to the people in addition to funding the regulation of the pot industry.

Proponents of AB1356 also say that by banning pot sales, local authorities are disregarding the wishes of the people in their areas. This is because there is overwhelming public support for legal marijuana.

The people who oppose the reversal of the promise in Prop 64 to let local authorities have a say in whether cannabis businesses should or shouldn’t be allowed in their areas say that this right was crucial in getting Prop 64 to pass. Reversing that promise would therefore tantamount to reneging on the principles which allayed the fears of some people and led them to support the ballot measure years ago.

Some people are also concerned about the risks associated with cannabis businesses since these businesses operate on a cash-only basis as a result of the federal status of marijuana. Marijuana is still illegal federally, so marijuana businesses cannot access banking services. This raises the risk of armed robberies and other opportunistic crimes. Local authorities should therefore reserve the right to allow or ban marijuana sales, they argue.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) call on all concerned to think carefully about the future they want for the cannabis industry so that this standoff between the state regulators and the local authorities is resolved in a way that puts the will of the people at the center.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

There’s minimal scientific information about the potential effects of the different drugs which pregnant mothers are discouraged from taking, but cannabis is singled out and given a very negative connotation even if there’s no proof to show whether it is as dangerous, or more dangerous, than pharmaceutical drugs. To set the record straight, researchers from the University of Washington are now recruiting study subjects to research how cannabis use during pregnancy affects babies after they are born.

The “Moms + Marijuana” study will document pregnant mothers’ use of marijuana from the first trimester of pregnancy until birth. The babies born will then have their brains scanned at six months of age to determine how prenatal marijuana use affects the cognitive, psychomotor and behavioral development of infants.

The study is focusing on pregnant women who are already using cannabis to manage the conditions, such as nausea, which they are suffering from during pregnancy. The objective is to find scientific proof either in support of, or contradicting the advice given to pregnant women to abstain from using marijuana.

To this end, the researchers are on a drive to recruit 70 pregnant women who are still in the first trimester of pregnancy. Half of these women will be in the test group while the other half will be in the control group.

Those in the control group will not be allowed to take any cannabis, tobacco or alcohol while those in the test group will be allowed to consume marijuana at least two times each week. The marijuana will be used to control morning sickness.

The researchers intend to conduct random drugs tests throughout the study in order to confirm that the pregnant women aren’t using any other drugs apart from what they are self-reporting to the researchers.

The test group of pregnant women are required to report their weekly marijuana use, and that marijuana can only be bought from licensed sources. The women will also send photos of the cannabis package so that the THC and CBD concentration in that marijuana will be recorded.

When the babies of the research subjects reach six months of age, they will be tested to establish their social and cognitive development, their motor and communication skills, their temperament and other behavioral markers.

Magnetic Resonance Imaging (MRI) scans will also be done while the babies are asleep. During those scans, the babies will be exposed to an odor of phenyl-ethanol. This substance is known to activate the sections of the brain which are associated with addiction and reward. The researchers want to use these scans to assess how prenatal marijuana use affects this part of the brain.

Once all this data has been collected, the researchers will compare the findings from the two groups and determine what role marijuana has had on the development of the babies. Youngevity International Inc. (NASDAQ: YGYI) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that this research will provide conclusive proof of whether prenatal cannabis use should or shouldn’t be recommended.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As the deadline set by Gov. Murphy to have the bill to legalize recreational cannabis passed approaches, the Department of Health has released the proposed rule changes which will see the medical cannabis program expanded. The program was due to be expanded at the same time as the legalization of recreational weed, but that seems to be failing as lawmakers fail to convince 2-5 other senators to support full legalization.

The rule changes are broadly aimed at improving access to medical marijuana. For example, there is a provision that will see the registration fee for patients and caregivers reduced to $100 from the current $200.

The new rules will also see veterans and seniors included among the categories of people who will pay a reduced fee of $20 when they apply to get a medical marijuana card. This will make access to the program more affordable for these groups of people.

When the new rules take effect, patients will now designate two people as primary caregivers instead of just one as was the case before. Having two authorized primary caregivers ensures that patients can still access medical marijuana even when one caregiver is indisposed.

The new rules will also allow more forms of medical marijuana to become available in the state. These include oil-based products, such as vape cartridges.

Currently, minors must undergo a psychiatric evaluation before a physician can certify or recommend medical marijuana for such patients. The new rules will remove this requirement, thereby easing the process of accessing medical marijuana by people who are underage.

The proposed rules will also see the addition of seven more conditions to the original list of medical marijuana qualifying conditions. The new ones include anxiety, PTSD, chronic pain and opioid use disorder. The expansion of the qualifying conditions will give more patients access to medical marijuana.

The drafters of the new rules have also included provisions which will reform the way permits are issued for cultivation, processing and dispensing medical marijuana. Currently, all permits are issued using the same system. This is going to change since the new rules provide for separate permitting systems for those different aspects of the industry.

Physicians will also be allowed to opt out of a list that is made available to the public showing which medical professionals have been approved to prescribe medical marijuana.

If Gov. Phil Murphy makes good on his threat, the new rules will be considered in a standalone bill separate from the one legalizing recreational cannabis. Unlike recreational weed which has attracted strong opposition, the lawmakers are in agreement regarding the expansion of the medical marijuana program and passing the medical marijuana bill will, in effect, make it harder to legalize recreational cannabis.

VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) hope that the lawmakers will find a middle ground that will see the expansion of the medical cannabis program and the legalization of recreational marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The Cannabis Business Summit & Expo 2019, hosted by the National Cannabis Industry Association, is set to take place at the San Jose McEnery Convention Center in San Jose, California from July 22 to 24, 2019. For the sixth straight year, the nation’s most influential, award-winning cannabis conference and trade show anticipates a strong showing of upwards of 10,000 attendees, bringing together the industry’s best and brightest minds to provide insight and showcase the latest developments shaping the cannabis space. The can’t miss event is designed for industry innovators as well as those looking for an entry point to network with like-minded peers and fellow entrepreneurs, engage with exhibitors, high-profile speakers and high-ranking cannabis executives, create meaningful connections and discover best practices from some of the biggest names in cannabis.

To view the full press release, visit http://cnw.fm/0RWuc

About the Cannabis Business Summit & Expo

Created by NCIA, #CannaBizSummit is the industry’s only association-backed, business-to-business event that empowers the industry through education and commerce. The show embodies the core values of NCIA–education, advocacy and community–to deliver invaluable insights and best practices to both the novice and experienced business owner. If you’re looking for the newest products and education that can provide you with the information you need to give you an edge in this market, #CannaBizSummit is the event you’re looking for. To learn more and register, visit www.CannabisBusinessSummit.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Medical marijuana was legalized in Ohio in 2016 and sales only started this year. Figures coming in from the state show that only 15,339 of the patients who hold medical marijuana cards have so far visited a dispensary and purchased medicinal marijuana products. Several factors can explain why just 49 percent of the cardholders have bought medical marijuana.

First, very few medical marijuana dispensaries have opened their doors to patients. Out of 56 dispensary licenses which were issued, just a paltry 15 establishments have started operating. These few dispensaries aren’t evenly distributed across the state, and this may explain why few patients have visited them and bought products.

Secondly, the price of the available products is still too high for many patients. The high prices may be resulting from the limited competition between the few dispensaries which have opened. Additionally, not many growers and processors are currently operating in the state. Prices are expected to reduce as more growers and processors come on board to supply the dispensaries in the state.

The state agencies involved in regulating the medical marijuana program also released other statistics related to the program.

For example, out of the 31,075 patients registered on the medical marijuana program, 171 have a diagnosis for a terminal illness, such as cancer. This could suggest that these people are taking medical marijuana to deal with pain.

The medical marijuana register also has 2,109 people registered as caregivers. Caregivers buy and administer medical cannabis to minors or people whose illness is so severe that they cannot buy and administer the medical marijuana by themselves.

In terms of sales, $5.8 million has been recorded as the revenue earned by medical marijuana businesses in the first four months of 2019. This is way below the potential of the industry since Ohio is ranked 7^th in the country in terms of its population and GDP.

In total, 750 pounds of marijuana plant material were sold by the medical cannabis dispensaries in the past four months. 3,610 units of manufactured cannabis products, such as oils and tinctures, were also sold.

Larger volumes of products are expected to be sold as medical marijuana becomes more readily available and as more people qualify for medical cannabis cards after more qualifying conditions were added to the initial list of 21 qualifying conditions.

TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) encourage all the entities that have received medical cannabis licenses to start operations quickly so that they can contribute to the growth of the medical marijuana industry in Ohio.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
A boom in demand for cannabidiol (CBD) has created an alarming shortage, which savvy hemp companies are aggressively looking to solve.

Cultivation supplies company Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has acquired several other suppliers, allowing it to benefit from economies of scale. Canadian cultivator Tilray Inc. (NASDAQ: TLRY) is investing heavily in new growing space. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED)has expanded from Canada into the United States and is collaborating with other companies to meet demand. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a substantial inflow of funds from a tobacco company and is investing some of it in R&D. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is focusing on growing high-quality hemp to supply a range of novel products.

To view the full editorial, visit http://cnw.fm/N7Pmg

To hear the CannabisNewsAudio version, visit http://cnw.fm/vs5Bu

About Sugarmade Inc.

Sugarmade Inc. is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include Zenhydro.com, AthenaUnited.com, CarryOutSupplies.com and BudLife Cannabis Storage Solutions. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Who’s going to deliver the keynote address at NCIA’s 6th Annual Cannabis Business Summit & Expo at the San Jose McEnery Convention Center in San Jose, California? Last year, it was James Cole, a former deputy attorney general who thinks that the federal government should treat cannabis as a medical pharmaceutical substance. The year before it was Vicente Fox; a former president of Mexico who set the tone at the 2017 conference with an insightful talk on the social injustices created by the war on drugs and the positive effects of global cannabis legalization.

This year’s event – the nation’s most influential, award-winning cannabis conference and trade show – promises to be no different. Expect a few headliners among the 10,000+ cannabis industry leaders and…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

As it becomes increasingly clear that the bill to legalize recreational marijuana is unlikely to get enough support in the New Jersey senate, lawmakers are beginning to consider the possibility of letting voters make the decision through a referendum in 2020.

It is now six weeks since a vote on the legalization bill was suddenly called off, but legislative leaders and Gov. Murphy don’t seem to have made any progress is securing the “2-5 votes” needed to guarantee that the legalization bill will pass on the senate floor. The Assembly doesn’t have the same problem and they are just waiting for the senate to be ready before they vote to pass the bill.

That wait doesn’t show any signs of ending soon, and some lawmakers are beginning to float the possibility of letting voters have the final say on marijuana legalization.

New Jersey is unique from other states because voters cannot initiate a referendum or ballot measure as it is known elsewhere in the country. Instead, legislators have to agree and draft the appropriate referendum question so that voters cast their ballots for or against the question presented.

Gov. Murphy laid down a deadline of end of May and threatened to expand the medical marijuana program administratively if the legalization bill isn’t passed by that time. Expanding the medical marijuana program would most likely spell doom for legalization by legislative means since there will be no urgency to debate and pass a standalone recreational marijuana legalization bill.

Sen. Nicholas Scutari (D-Union County), who drafted the legalization bill, is of the opinion that pursuing legislative means to legalize recreational marijuana would bring better and faster results than using a referendum to change the law.

Scutari added that for a referendum to be binding, it needs to be drafted to the effect that the constitution would be amended to allow recreational marijuana in the state. The state should only resort to a referendum if all else fails, he affirmed.

Gov. Phil Murphy is interested in seeing the recreational marijuana bill passed, but the cries of patients who want to see the medical marijuana program expanded may force him to act on having the medical marijuana expansion bill passed on its own. For example, the six existing dispensaries are woefully inadequate to serve the more than 40,000 medical marijuana cardholders.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and Sugarmade Inc. (OTCQB: SGMD) call on the lawmakers to put aside their differences so that the people of New Jersey aren’t forced to wait for years before recreational marijuana is legal in the state.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Edible medical cannabis products are now legal in Maryland after Gov. Larry Hogan signed two related bills on Monday this week (May 13). Medical marijuana businesses stand to boost their revenue potential with the addition of these products to their offerings.

The medical marijuana edibles bill was signed along with a related antitrust law on the same day. There are three major highlights of those two laws as explained below.

First, no single individual or business entity will be allowed to get more than four medical marijuana dispensary licenses in the state. This provision is intended to spread the economic opportunities in the industry to as many individuals as possible. The lawmakers didn’t want to see a situation in which “Big Marijuana” sets foot in the state and dominates the entire industry, to the detriment of small players.

Another provision states that the regulators of the medical marijuana industry will not grant an applicant more than one cultivation or processing license. This clause is also intended to ensure that there is rigorous competition in the industry since many players will be involved in cultivating and processing medical marijuana in Maryland. Innovation will flourish as a result, because growers and cultivators will be hard at work looking for more cost-effective ways to grow or process medical marijuana.

Universities and other research institutions were also allowed to purchase medical marijuana for purposes of conducting research. This provision clears any gray areas which may have existed in the medical marijuana laws that set requirements for a person who wishes to buy, possess and consume medical cannabis.

Under the previous law, research institutions couldn’t get their hands on medical marijuana because they aren’t patients, and they therefore needed to go through a lengthy, often unclear process to get special permission from regulators in order to access medical marijuana. The legal change clarifies how research institutions can access medical marijuana.

Medical marijuana sales started towards the end of 2017 across the state. By the end of 2018, medical marijuana sales grossed nearly $110 million. Figures released by the state show that the first quarter of this year (2019) has seen medical cannabis sales totaling $49 million. The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) hope that the passing of these two laws will provide an added impetus to the industry so that the annual sales hit higher and higher levels as the industry matures.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Medical marijuana provisioning centers (dispensaries) have started delivering medical cannabis to the front doors of patients who order for products online. Utopia Gardens LLC, based in Detroit, was the first dispensary to take advantage of the legal changes permitting medical cannabis delivery.

Donnell Cravens, the manager of Utopia Gardens, explains that home delivery was a better way to serve patients, some of whom were undergoing chemotherapy which made it hard for them to move out of their homes in order to buy medical marijuana products.

According to LARA, the state body charged with regulating the medical cannabis industry in Michigan, three dispensaries have so far received licenses to start offering medical cannabis home delivery services. The three companies are Utopia Gardens, BotaniQ (also based in Detroit) and Lake Effect Group which is based in Portage.

Patients who wish to take advantage of the home delivery service must have their medical cannabis cards verified by the dispensary before the products are dispatched. Deliveries can only be done to the address indicated on the medical marijuana card, so patients need to update their records with LARA if they are to benefit from this service.

Some of the first patients to place and receive their orders from Utopia Gardens in Detroit described the online ordering process as “easier than making a purchase through Amazon.” Any products ordered typically take 45 minutes to be delivered to one’s address.

While the delivery service itself is free, there are minimum order sizes depending on where a patient wants the medical cannabis to be delivered. For example, those patients who reside within Wayne County must place an order that is worth at least $50. However, those who stay in Oakland and Macomb Counties must up their orders to at least $100 so that the cost of delivering the products doesn’t erode the margin of the provisioning center.

Patients can also call the provisioning center to place their order instead of going online. In such a case, the caller will be asked to provide details which will enable the dispensary to verify that he or she is a registered patient and is allowed to purchase, possess and use medical marijuana in Michigan.

Donnell Cravens also revealed that patients who order for medical cannabis home deliveries must be prepared to pay for the products by debit card. This requirement is intended to protect delivery staff from any security risks which may result from receiving cash from patients who have received their medical cannabis orders.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) congratulate Utopia Gardens LLC upon a smooth start to the home delivery service. The positive feedback from patients speaks volumes about how much thought went into debuting the service.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

One would imagine that once a country or jurisdiction legalizes medical cannabis, then the patients there will find it easy to access prescription medical cannabis products. Sadly, this isn’t the case as panelists and attendees of the Medical Cannabis Conference in Toronto last week revealed.

The first major challenge that medical cannabis patients face is the high prices of products. A clear example of this is in Canada which has had medical marijuana since 2001.

Gerald Major, who is the president of a medical cannabis advocacy group in Canada called Canadians for Fair Access to Medical Cannabis, revealed during the conference that the legalization of recreational marijuana in Canada has made matters worse for patients taking medical cannabis.

For example, the high taxes imposed on recreational marijuana have increased the cost of medical marijuana as well. Additionally, the supply shortages in the recreational segment have also reduced inventory for the medical cannabis retailers, and this has forced patients to underdose or go without medical cannabis for a while.

Furthermore, restrictions that didn’t exist earlier have now been imposed on medical marijuana users as well. For example, no exceptions for medical cannabis patients have been made in the rules governing driving while impaired. Gerald Major says such traffic stops are likely to victimize patients using medical cannabis and yet the patients face a bigger impairment threat from the conditions which they are treating rather than the cannabis medication that they consume.

Patients using medical cannabis in Europe also don’t seem to be faring any better. A panelist from Germany and another from the UK revealed that the red tape one must bear in order to get a medical cannabis prescription is extraordinary.

For example, in the UK, specialist doctors must complete a lot of paperwork to the effect that conventional treatment options have been exhausted and the last resort is to try medical marijuana. The requirements make doctors responsible for treating patients with medical marijuana, but doctors are reluctant to prescribe medical marijuana because they don’t have sufficient literature to enable them feel comfortable about prescribing medical cannabis.

In addition to that, the cost of medical marijuana is very high in European where it is legal, and more than a third of all reimbursement claims to insurance companies are rejected for no clear reason. The lack of insurance cover for medical cannabis has put medical marijuana products out of reach for most patients because the cost is prohibitive.

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) agree with the panelists that urgent steps need to be taken to remove all the barriers to access to medical marijuana in all jurisdictions where it is legal.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

MjMicro Conference (www.mjmicro.com), the next-level investor forum for publicly traded cannabis companies, debuts in New York City on June 25 at the Westin Grand Central Hotel. This one-day conference provides an exceptional opportunity for cannabis-related public entities to connect with private capital investors and also features presentations from noted industry experts.

The MjMicro Conference is an invitational networking forum exclusively created to enable best-in-class and emerging public companies in the cannabis industry to meet with high-net-worth investors, venture funds and family offices, helping drive private investment capital into public entities, promote trading liquidity, and increase media and analyst coverage.

“Our goal is to provide both the most exciting and diverse range of public company investment opportunities, ranging from micro to mid-cap companies that have proof of concept, revenue streams, audited financials and public market liquidity,” noted George Jage, president of MjLink.com and producer of MjMicro. “This event creates direct C-suite access for investors to provide insight into their vision, strategy and performance.”

Confirmed presenting companies include 1933 Industries (CSE: TGIF) (OTCQX: TGIFF), CannAmerica Brands (CSE: CANA) (OTCQB: CNNXF), Cannex Capital Holdings (CSE: CNNX) (OTC: CNXXF), Cardiol Therapeutics (TSE: CRDL) (OTC: CRTPF), Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), (Frankfurt: 0QV), Emerald Health Therapeutics, FSD Pharma (CSE: HUGE) (OTCQB: FSDDF), Helix TCS Inc. (OTCQB: HLIX), High Tide Inc. (CSE:HITI) (OTCQB:HITIF), House of Jane, Province Brands of Canada, MJ Freeway, Tauriga Sciences (OTCQB: TAUG), United Cannabis Corp. (OTCQB: CNAB), and Vireo Health (OTC: VREOF).

“FSD Pharma, a spotlight presenter, is endemic of the exciting opportunities in the market. They are a Canadian licensed producer developing cutting-edge technology and conducting research related to the treatment of chronic pain, fibromyalgia and other medical conditions that are typically treated with pharmacological applications,” noted Todd Markey, director of investor relations at MjMicro.

“There are over 400 cannabis-related public companies in the market today, and we project that anywhere between 100 and 200 others will get listed in the next 24 months,” stated Jage. “There has been a race for cannabis companies to access the public capital markets, but the industry lacks the access to institutional capital that you would expect in such a fast-growth industry. This event provides the solution on both sides of the table.”

MjMicro is scheduled to be held four times a year with events in New York, Beverly Hills, West Palm Beach and Seattle.  MjMicro is produced by MjLink.com Inc., which is a wholly owned subsidiary of Social Life Networks (OTC: WDLF).

To learn more about MjMicro Conference or to request an invitation to attend, sponsor or present, please visit https://www.mjmicro.com.

About MjLink.com Inc.

Social Life Network (OTC: WDLF), a cloud-based social media and social network technology company based in Denver, Colorado, announced on Sept. 25, 2018, that the Company had spun its cannabis technology division out of the parent company and incorporated MjLink.com Inc., a Delaware Corporation, as its wholly owned subsidiary. MjLink operates as a multinational cannabis technology and media organization with two separate social networks: WeedLife.com, a consumer-to-consumer network; and MjLink.com, a business-to-business social network. On April 4, 2019, the president of MjLink, George Jage, announced the launch of a new division of the Company that is focused on providing the industry with best-in-class financial, B2B and B2C cannabis-centric events that complement the Company’s global social networks.

For more information about Social Life Network and to download the MjLink Investor Deck, visit https://social-life-network.com

Disclaimer

This news release may include forward-looking statements within the meaning of section 27A of the United States Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company’s analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company’s or MjLink’s future financial results, revenues or stock price. There are no assurances that the Company will successfully take MjLink.com, Inc public. These statements are made under the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein. The relationship between Social Life Network and the other companies mentioned currently does not extend beyond inviting them to send representatives to speak at the MjMicro Conference.

Contact:

Investor Relations:
[email protected]
855-933-3277

Corporate Communications:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

This article contains Third-Party Content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion.

Multifaceted financial news and publishing company CannabisNewsWire (“CNW”) will serve as the official newswire and gold sponsor for National Cannabis Industry Association’s (“NCIA”) 2019 Cannabis Business Summit & Expo. The event, expected to draw thousands of the cannabis industry’s best and brightest, is scheduled to take place at the San Jose McEnery Convention Center in San Jose, California from July 22 to 24, 2019. “The Cannabis Business Summit & Expo continues to foster remarkable opportunities for those involved in every facet of this growing, global industry,” CNW Director of Syndicated Communications Christopher Johnson said in the news release. “We are thrilled to be part of this exciting journey as a gold sponsor of this highly anticipated conference. The National Cannabis Industry Association’s ability to successfully broaden horizons and energize members of the cannabis industry and beyond is a testament to its vital role in this emerging space.”

To view the full press release, visit http://cnw.fm/8VbTq

About the 2019 Cannabis Business Summit & Expo

The 2019 Cannabis Business Summit is expected to draw more than 7,500 of the cannabis industry’s best and brightest entrepreneurs, policymakers, thought leaders and newcomers to this burgeoning sector. More than 85 percent of participants bring purchasing power or decision-making authority to this innovative event that features emerging topics, relevant policy issues, business solutions, deep data insights, market opportunities and much more. The latest products and services will be showcased by a diverse selection of exhibitors, enabling one-on-one interactions and meaningful connections, while five education tracks focus on achieving new levels of success in business. To learn more and register, visit: www.CannabisBusinessSummit.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: A boom in demand for cannabidiol (CBD) has created an alarming shortage, which savvy hemp companies are aggressively looking to solve.

Cultivation supplies company Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) has acquired several other suppliers, allowing it to benefit from economies of scale. Canadian cultivator Tilray Inc. (NASDAQ: TLRY) is investing heavily in new growing space. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has expanded from Canada into the United States and is collaborating with other companies to meet demand. Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) has received a substantial inflow of funds from a tobacco company and is investing some of it in R&D. Charlotte’s Web Holdings Inc. (OTCQX: CWBHF) (CSE: CWEB) is focusing on growing high-quality hemp to supply…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Tired of the endless cannabis shortages which have threatened to hand the legal cannabis industry back to the black market, Health Canada has come up with a new way to increase how soon a newly licensed cultivator can start growing cannabis.

The solution that Health Canada wants to start implementing entails giving production licenses to entities which already have a cultivation facility ready.

This means that companies which want to grow cannabis will have to first construct the greenhouses they intend to use so that the facilities can be ready for inspection by Health Canada. Facilities which pass the inspection can then be licensed to start operation immediately.

This new approach is likely to favor the bigger players at the expense of smaller entities which want to enter the cannabis cultivation space.

For example, Aphria has been waiting for its new Ontario-based cultivation site to be approved by Health Canada for more than a year. If this new rule had been in place from the very start, Aphria would have started cultivation long ago, thereby getting a head-start in the market while other entities without ready grow facilities play catch up.

The key question is, will this change in the regulatory approval process bring the cannabis shortage to an end?

The realistic answer is that the move will have a very small difference in fixing the problems causing marijuana shortages in Canada. For example, one of the reasons for the persistent shortages is that it has been difficult for harvested marijuana to be processed and packaged due to a shortage of packaging materials which meet the strict requirements set by Health Canada.

Many cultivators have cannabis which cannot be released onto the market because it hasn’t been packaged in a way that complies with the Cannabis Act. Speeding up how soon a licensed firm starts growing cannabis will not fix this packaging nightmare.

Another reason why switching to licensing cultivators who already have grow facilities may not solve the supply shortages is the red-tape at Health Canada. Many entities have been waiting for over a year to have their license application considered even without the requirement to have ready cultivation facilities. It is hard to imagine how the processing of applications will miraculously speed up just because Health Canada now says they will give priority to applicants with cultivation facilities already set up.

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element Inc. (NASDAQ: NETE) look forward to the time when Health Canada fixes all its internal issues which have played a part in perpetuating the cannabis shortages in the country.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Thirty-eight attorneys general have written a letter to Congress asking the lawmakers to pass legislation which will enable the banking industry to receive money from legitimate marijuana businesses. The attorneys general are from different states and territories where marijuana is legal in some form.

While more than 33 states have legalized medical marijuana and 10 states plus the District of Columbia have legalized recreational cannabis, the federal government still regards marijuana as an illegal substance. This federal government position means that banks face a risk of federal enforcement action if money from the cannabis industry finds its way into any bank.

Consequently, most banks have been reluctant to accept marijuana companies as clients, and those that do charge high fees which make it very costly for cannabis businesses to access the most basic of banking services.

The attorneys general say this situation has created a public safety nightmare since the large amounts of cash held by cannabis businesses are an attractive target to criminals. They therefore call on Congress to pass the SAFE Banking Act or any other similar legislation so that the $8.3 billion cannabis industry can be admitted into the banking system.

Once all this money goes through banks, it would be easy for tax authorities to trace it in order to confirm that the cannabis companies are paying taxes as they should. Public safety will also be enhanced because the chance of robberies will have been reduced if cannabis businesses aren’t holding a lot of cash in their premises.

Towards the end of March this year, the Financial Services Committee of Congress advanced the SAFE Banking Bill and it now has 175 bipartisan co-sponsors.

The letter from the attorneys general shows how much support such a practical requirement attracts from state authorities who are at the forefront of this legal gray area in which legitimate cannabis businesses are entitled to all services like other businesses but federal law looks at them as pariahs.

Insiders say that the major stumbling block to the enactment of the SAFE Banking Act seems to be the senate leadership that don’t see the matter as a priority even if the bill may have sufficient votes to pass.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) and MustGrow Biologics Corp. hope that the voices of different groups, such as the attorneys general, finally get Congress and the Senate to pass this commonsense law to allow states to make and enforce their own marijuana laws, which include giving banks assurances that they will not be sanctioned for working with the legal marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Look around your home and nearly half (or even more) of the products you see may have been made in China. Now China has jumped into the fray and it is bringing loads of CBD to the market in cosmetics, ingestible oil and other products.

This boom is largely centered in just two of China’s 34 provinces. These provinces are cultivating the plants even if Chinese law is very strict on psychotropic drugs, with death sentences routinely handed out to drug traffickers.

Hanma Investment Group is one of the first companies that secured a license to grow cannabis in Southern China in 2017. The CBD extracted is marketed outside China in balms, oils and sprays.

Hanma Investment Group has a subsidiary that is cultivating industrial hemp on more than 1,600 acres in Yunnan Province.

For thousands of years, hemp and marijuana were widely grown across China for making ropes, fabrics, paper and for medicinal purposes until the People’s Republic of China was founded and clamped down on the plant in 1949.

Hemp was also outlawed in 1985 when China signed the UN Convention on Psychotropic Substances despite hemp having just trace amounts of THC.

It is only recently (2010) that China softened its stance and allowed Yunnan province to resume growing hemp for textiles, especially for making uniforms for the People’s Liberation Army.

The exploding interest in CBD around the world has made Yunna Province to add oil extraction to the growing list of products for which hemp is grown. This booming industry has breathed new life into the economy of Yunna since farmers can earn much more from growing hemp ($300 from an acre) when compared to growing other crops, such as rapeseed or flax.

Yunna Province now has four companies that have, in total, opened more than 36,000 acres of land for hemp cultivation.

The other province which is reaping from hemp is Heilongjiang Province. Other provinces are catching on and plans are underway to license companies to start growing hemp in more regions of China.

The announcements that different companies have started growing hemp have caused such a stir on the stock exchanges that regulators were forced to intervene and stop trading in the shares of those companies.

Chinese companies are also aggressively staking their claim on the U.S. hemp landscape. For example, Hanma Investment Group has acquired a CBD extraction plant in Las Vegas, Nevada, and it has also set its eyes on Canada as well.

The 2018 Farm Act removed hemp from the list of controlled substances and it is now an agricultural commodity like any other within the U.S. The onus is now on U.S. companies to take full advantage of this legal reform so that China doesn’t muscle out local players in the CBD industry. Marijuana Company of America Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) hope that U.S. companies are up to the challenge so that foreign firms don’t dominate the local CBD market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The government in Ontario has enforced the penalties which were written into the conditions for the businesses that were selected to open the first offline cannabis retail stores. The businesses were mandated to open for business by April 1 this year.

Hundreds of companies applied for brick-and-mortar recreational cannabis retail store licenses. However, the province decided to use a lottery to select just 25 businesses because of the persistent supply shortages in the country. The regulators felt that it would be pointless to license many businesses yet those businesses could not be certain that they would have access to inventory to remain operational.

While the method to select which businesses would receive the first set of licenses was rather unorthodox, there was nothing lax about the stringent conditions which were given to the successful applicants.

One of those conditions required each applicant to provide a $50,000 letter of credit to be entered in the draw. Money would be drawn against the letter of credit as a penalty based on how late that business was in opening its doors to the public.

The first installment of penalties was imposed on the businesses which didn’t open by April 1 and more money was drawn against the letters of credit of the entities which hadn’t opened by April 15.

It should be noted that less than half of the 25 licensees opened by the deadline set by the provincial government.

The recent announcement by the Ontario Alcohol and Gaming Commission that a final draw down was made against the letters of credit of seven businesses which failed to open by April 30 means that the affected businesses have lost the entire $50,000 indicated in the letter of credit.

It isn’t yet clear whether the provincial government is entirely blameless in these delays to open. For example, was the time given to the businesses to meet all the licensing requirements, such as obtaining approval from the local authorities where the businesses wish to operate sufficient, or the province was unrealistic in the deadlines set?

The reality dawning upon those who wish to run cannabis businesses in Ontario is that no one will be spared if they aren’t serious about making use of the license given to them. Ontario means business on matters of recreational cannabis!

Hemptown USA and Green Hygienics Holdings Inc. (OTCQB: GRYN) sympathize with the entrepreneurs who have lost their entire $50,000 letters of credit and hope that there is a mechanism for them to plead their case before the regulators if there were genuine unavoidable reasons for the delay in opening shop.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
The growth of vaping has led to the emergence of a new sector.

• Vaping is tied to the tobacco and cannabis industries but has become popular as a healthier delivery system for both products.
• Investment and mergers are fueling the industry’s expansion.
• Working smarter in the competitive market may be savvy strategy.

Many companies are jockeying for position in this new space. Interestingly, some of the more successful companies may not necessarily be the big players but those that work smart with what they have. Among these smaller smart companies is VPR Brands LP (OTC: VPRB) (VPRB Profile), which has used innovative products and marketing tactics to expand its customer base. At the opposite end of the spectrum is Altria Group Inc. (NYSE: MO), a tobacco giant that has invested heavily in vaping. Greenlane Holdings Inc. (NASDAQ: GNLN) works on the distribution side and has impressive reach, supplying nearly 10,000 stores and two major online outlets. KushCo Holdings Inc. (OTCQB: KSHB) has moved successfully from packaging into cannabis. Thanks to cannabis-based medicines such as those created by GW Pharmaceuticals plc (NASDAQ: GWPH), vaping may even develop a place in medical care.

To view the full editorial, visit http://cnw.fm/o62bO

To hear the CannabisNewsAudio version, visit http://cnw.fm/On1f9

About VPR Brands, LP

VPR Brands is a technology company whose assets include issued U.S. and Chinese patents for atomization-related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices that deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information, visit the company’s website at www.VPRBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Related Editorial
Last year was a year of maturation for the cannabis market.

• California’s growing pains are a recipe for success for handful of savvy operators
• Brands, consistency and scalability likely deciding factors for many companies
• Projected global market size an open-and-shut case for scaling up NA sector

The market growth resulted from retailers in nine legal adult-use states being pushed beyond the sector’s historically core demographics, targeting fast-growing new segments such as women, with an emphasis on elements such as wellness and clearly labeled/low-dose alternatives. That trend was reinforced with CBD breaking out into the mainstream, as industrial hemp became legal throughout the United States, and cannabis companies looked for ways to stand out from the crowd. Some companies were more successful at this than others, with TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) making huge strides recently to expand the upper-end procurement part of the business, as well as flesh-out its footprint of branded offerings. Other moves have been made by comparable sector players such as Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), DionyMed Brands Inc. (OTCQB: DYMEF) (CSE: DYME), Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. (OTCQX: ORHOF) (CSE: OH), which are pursuing similarly comprehensive approaches to the sector that run the gamut from raw inputs to changing branding, marketing and distribution methods.

To view the full editorial, visit http://cnw.fm/n6vGM

To hear the CannabisNewsAudio version, visit http://cnw.fm/T6Azr

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://cnw.fm/TCAN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Data collected shows that cannabis sales were higher on 4/20 in line with the predictions that had been made regarding the effect of the marijuana “holiday” on sales. Headset, a cannabis industry analysis company, had initially predicted a 100 percent increase in sales on that day.

The data that they collected shows that marijuana sales on 4/20 actually exceeded what had been predicted since sales increased 128 percent when compared to the volume of sales registered on the previous four Saturdays.

The report released by Headset also shows that the “eve” of 4/20 was also good for cannabis retailers since sales increased by 27 percent when compared to the sales of the previous four Fridays. Historical data shows that Fridays are normally good days for cannabis businesses, so the fact that this particular Friday happened to be the “eve” of 4/20 provided an added reason for marijuana users to open their wallets.

The report released by Headset was based on real-time data collected via the POS (point-of-sale) systems of cannabis retailers who agreed to link their systems to the data analytics system of Headset.

In terms of sales data from different states, shoppers in Maryland spent the most on cannabis on 4/20 because the average shopper spent approximately $105 before tax on that day. Shoppers in Oregon spent the least amount on that day, with the average amount spent by each buyer totaling just $36. More mature cannabis markets like Colorado and Nevada saw the average expenditure being about $50 while this figure jumped to $76 when the data on the largest marijuana market in the world (California) was analyzed.

In terms of experience level, just 25 percent of buyers where beginners while the majority of the people who bought cannabis on 4/20 were intermediate users of pot.

Two-thirds of marijuana shoppers on the holiday were people aged between 21 and 34 years of age. Senior citizens (aged 55 and above) only took 4 percent of the population of cannabis shoppers on that day.

More than half of all cannabis buyers bought cannabis flower while a third of the buyers purchased cannabis concentrates. Marijuana edibles completed the list of the products most bought on 4/20.

A further analysis shows that the most popular items on that day were the products that could be consumed as soon as a shopper left a dispensary or retail outlet. Cannabis beverages therefore registered a 136 percent growth rate when compared to other products.

Global Payout Inc. (OTC: GOHE) and Geyser Brands Inc. (TSX.V: GYSR) are pleased to learn that the findings of the sales data on 4/20 shows that despite increasing legalization across the U.S., cannabis hasn’t lost its novelty among buyers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Gov. Brian kemp has signed a bill that will make it possible for licensed entities to produce and distribute oils and other products which have limited amounts of plant-derived THC.

House Bill 324 also lays the ground for the establishment of a commission to regulate and oversee the production, manufacture and dispensing of products having the specified amounts of THC to patients who have been registered to receive those products.

Under the bill which has now been signed into law, the state will cooperate with Georgia University to manufacture THC-infused extracts and oils. A maximum of six cultivators will be licensed to operate within the state, according to the new law.

Medical marijuana was legalized in Georgia in 2015. However, the law which legalized this form of medicine didn’t establish mechanisms through which qualifying patients could access low-THC cannabis oils and extracts.

The latest law is intended to fix that shortcoming so that patients can access state-regulated cannabis oils and extracts instead of merely taking comfort in a law which allows them to use these products yet no system is in place to avail the permitted products.

Currently, about 9,500 patients have been approved to use medical cannabis oil. The law sets a possession limit of 20 fluid announces of medical cannabis oil whose THC concentration doesn’t exceed 5 percent.

A registry card issued by the Georgia Department of Public Health protects members of the public from being arrested and prosecuted for possessing a controlled substance.

The state has a small number of patients on its medical marijuana program because Georgia enacted a highly restrictive medical marijuana law.

Under the law, medical marijuana cannot be used in leaf or edible form as is the case in nearly all other jurisdictions where medical marijuana is legal. Vaporization of cannabis oil is also banned in the state.

Additionally, Georgia doesn’t give physicians the right to prescribe cannabis oil to patients. Instead, the physician simply fills a patient certification form confirming that the patient has one of the 17 qualifying conditions, and then the physician and the patient sign a waiver form before the patient certification form is mailed to the Department of Public Health for consideration.

It remains to be seen whether the enactment of the law facilitating the manufacture and sale of cannabis oil will result in an increase in the number of people who apply for the Low THC Oil Registry Card.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP) hope that Georgia will enact other reforms soon so that its medical cannabis program expands to the level that other states have reached.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Multifaceted financial news and publishing company CannabisNewsWire (“CNW”) this morning recapped the O’Cannabiz 2019 conference and expo held at The International Centre in Toronto, Canada from April 25 through 27. Voted Canada’s No. 1 cannabis event by High! Canada Magazine, the conference drew more than 7,000 attendees and key players from the budding industry. “Attending O’Cannabiz was an incredible experience,” CNW Director of Communications Jonathan Keim said in the news release. “The conference space was doubled in size for this year’s event, covering 100,000 square feet, and the expo floor was fully sold out. This attests to the leading position of O’Cannabiz and its ability to attract top cannabis industry players.”

To view the full press release, visit http://cnw.fm/143kH

About The O’Cannabiz Conference and Expo

The O’Cannabiz Conference and Expo is a gathering of the complete Canadian and International industry conducting high level networking under one roof. It is a full-spectrum cannabis B2B event that connects thousands of expert companies and brands integrated in the full 360 degrees of the industry. These include: lighting, nutrients, greenhouse construction and supplies, peer-reviewed agri-practices, lifestyle, medical and legal issues, marketing, the hiring of professionally trained growing staff, best financial and investment advice, quality control and market analyses. It is, in short, a buffet of best-business practices. And it’s your best opportunity to source… shop… network… and grow. To learn more about the O’Cannabiz Conference and Expo, visit https://ocannabiz.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

The government in New Zealand has released details of how a referendum will be conducted in 2020 on the legalization of recreational marijuana. The plan was released by Andrew Little, the Justice Minister, in a press release.

The three parties which make up the current government agreed on the basic elements of the plan through which recreational marijuana use will be regulated, taxed and commercialized for adults 20 and above. The outcome of the vote will be binding, so voters shouldn’t have any fears that the government will not implement the decision of the people.

In the proposal, people will be allowed to grow a limited number of cannabis plants and licenses will be issued to places where recreational consumption can be done outside the privacy of people’s homes. Marijuana advertising will be highly restricted as well.

For the voters to make a decision, the referendum question needs to be as clear as possible so that if approval is given, voters know what legalization model they have voted for. This will prevent the lack of clarity on how to implement the decision of voters as is playing out in Britain after voters approved Britain’s exit from the EU but how to implement that decision has proved to be more divisive than the referendum on Brexit.

Andrew Little revealed that the cabinet decided to hold the referendum on full legalization because simply decriminalizing recreational cannabis would not provide the public health safeguards the country needs in order to protect the youth and help those who are addicted.

The minister also outlined the primary and the secondary objectives of the legalization bill which will be formulated so that voters decide based on the contents of that draft bill. These objectives include disempowering the illegal cannabis trade, ensuring cannabis product safety through the control of THC concentrations, and fiscal sustainability.

The legalization plan outlines the timelines for different activities which will be done in the run up to the referendum in 2020. These activities include inter-party consultation, receiving and analyzing feedback from stakeholders about the legalization model and voter education about the entire legalization plan after all the relevant documents have been printed and disseminated widely across the country.

If recreational marijuana is finally legalized through the referendum, New Zealand will be the first country in the world to legalize adult-use marijuana through a referendum. Uruguay and Canada took a legislative route.

ChineseInvestors.com, Inc. (OTCQB: CIIX) and Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) applaud the government in New Zealand for taking the time to formulate a detailed plan through which the people will be asked to make an informed decision about recreational cannabis. All that is left is to implement the plan and respect the decision made by the voters.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Michigan has been struggling to get a handle on the illegal cannabis market and their latest action has seen them instruct medical marijuana provisioning centers to stop accepting cannabis grown by caregivers and instead only accept supplies from growers licensed by the state.

LARA (Licensing and Regulatory Affairs) also says that caregiver growers can start selling cannabis to the licensed growers and processors, but the caregiver growers will have to meet the cost of testing their cannabis before the licensed processors and growers can accept it.

Rejecting the cannabis grown by caregivers is just another twist in the regulatory chaos as the state struggles to move from a largely informal industry to a regulated one. Their efforts in this direction have been met by legal challenges initiated by the unlicensed cannabis businesses which the regulators wanted to close.

Judge Stephen Borrello of the Court of Claims has variously described what the regulators are doing as “freakish or whimsical.” The Judge has so far made several rulings against LARA, the most recent being one in which unlicensed dispensaries can continue operating for 60 days after LARA has rejected their application for a license.

During that court session, the judge gave the regulators the liberty to decide whether caregiver growers could continue supplying medical cannabis to dispensaries. The regulators promptly acted on that and issued their guidelines barring caregiver growers from taking their cannabis to dispensaries.

This action by LARA has stirred what is an already sour relationship between the “corporate cultivators” and the caregiver cannabis growers. The caregiver growers see the large corporate cultivators as being only interested in making profit at the expense of patients while the big growers see caregiver growers as people who supply cannabis of questionable quality to undercut their profits.

Those accusations have some basis, because some of the cannabis from caregiver growers has tested positive for mold, E-coli, Salmonella and other contaminants. Nonetheless, consumers prefer the cannabis from caregiver growers because it is more affordable and is in tune with the needs of patients.

Critics of the action taken by LARA now say that the caregiver growers are simply going to start supplying the unlicensed sellers, to the detriment of the legal cannabis industry since these products will not have to undergo the costly testing processes required in the regulated market.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) hope that the regulators take well-considered decisions so that the medical cannabis industry in Michigan can finally stabilize.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

CannabisNewsWire Editorial Coverage: The growth of vaping has led to the emergence of a new sector.

• Vaping is tied to the tobacco and cannabis industries but has become popular as a healthier delivery system for both products.
• Investment and mergers are fueling the industry’s expansion.
• Working smarter in the competitive market may be savvy strategy.

Many companies are jockeying for position in this new space. Interestingly, some of the more successful companies may not necessarily be the big players but those that work smart with what they have. Among these smaller smart companies is VPR Brands LP (OTC: VPRB) (VPRB Profile), which has used innovative products and marketing tactics to expand its customer base. At the opposite end of the spectrum is Altria Group Inc. (NYSE: MO), a tobacco giant that has invested heavily in vaping. Greenlane Holdings Inc. (NASDAQ: GNLN) works on the distribution side and has impressive reach, supplying nearly 10,000 stores and two major online outlets. KushCo Holdings Inc. (OTCQB: KSHB) has moved successfully from packaging into cannabis. Thanks to cannabis-based medicines such as those created by GW Pharmaceuticals plc (NASDAQ: GWPH), vaping may even develop…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CannabisNewsWire Editorial Coverage: Last year was a year of maturation for the cannabis market.

• California’s growing pains are a recipe for success for handful of savvy operators
• Brands, consistency and scalability likely deciding factors for many companies
• Projected global market size an open-and-shut case for scaling up NA sector

The market growth resulted from retailers in nine legal adult-use states being pushed beyond the sector’s historically core demographics, targeting fast-growing new segments such as women, with an emphasis on elements such as wellness and clearly labeled/low-dose alternatives. That trend was reinforced with CBD breaking out into the mainstream, as industrial hemp became legal throughout the United States, and cannabis companies looked for ways to stand out from the crowd. Some companies were more successful at this than others, with TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (TCAN Profile) making huge strides recently to expand the upper-end procurement part of the business, as well as flesh-out its footprint of branded offerings. Other moves have been made by comparable sector players such as Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), DionyMed Brands Inc. (OTCQB: DYMEF) (CSE: DYME), Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. (OTCQX: ORHOF) (CSE: OH), which are pursuing similarly comprehensive approaches to the sector that run the gamut from…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Two bills dealing with access to medical marijuana by veterans are slated to be voted on by a congressional committee today (Wednesday, May 8). This vote comes barely a week after the Veterans’ Affairs Subcommittee of Health conducted a hearing on the bills.

One of the bills up for a vote has to do with allowing VA doctors to prescribe medical marijuana. This bill also seeks to codify into law an existing policy which protects the VA benefits of veterans who use medical cannabis in accordance with state law.

The second bill that will be voted on seeks to compel the VA department to conduct research about the medicinal effects of cannabis for the common conditions which veterans suffer from. These include post-traumatic stress disorder and chronic pain.

A third bill which isn’t going to be voted on focused on allowing VA doctors to recommend medical cannabis for veterans who can be helped by the substance. This bill, sponsored by Rep. Earl Blumenaeuer, will not be voted on because its contents are already included in another bill that has been scheduled for a vote.

The broader bill also includes a clause which stops VA doctors from making medical records that state that a veteran suffers from “substance abuse disorder” if that individual uses cannabis in a state where marijuana is legal.

Another clause which was added to that bill asks the VA secretary to generate new diagnostic codes tailored to cannabis use.

Advocates have urged the Veterans’ Affairs committee to take action now so that veterans no longer have to go underground to access medical cannabis to relieve their symptoms. The advocates added that medical marijuana is here to stay, so there is no point in continuing to think along prohibitionist lines.

These bills to be voted upon mark yet another step in the push to reform federal marijuana laws. In March, another House committee passed a bill which intends to protect banks from federal prosecution resulting from the banks’ dealings with state-legal marijuana companies.

These bills being fronted in different House committees are in line with the “blueprint” designed by Rep. Blumenaeuer last year. In that blueprint, the congressman urged different committees to push through marijuana law reforms that fall in the ambit of their committees so that at the end of that process, the overall federal marijuana policy will have been overhauled.

Earth Science Tech, Inc. (OTCQB: ETST) and Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) hope that the bills are passed by the House committee and the entire Congress so that the men and women who have served this nation in the armed forces access medical marijuana in their time of need.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

The production of marijuana in Oregon is so high that the Oregon Liquor Commission estimates that the available inventory can address the supply needs of the state for nearly 7 years if demand remains at the current level. This overproduction has prompted lawmakers to consider exporting the excess cannabis to other jurisdictions where recreational marijuana is legal.

Senate Bill 582 is a preemptive step aimed at getting Oregon ready to move fast once the federal government relaxes its marijuana laws. Currently, marijuana is a schedule 1 controlled substance which cannot cross state lines.

Cannabis law reform at the federal level is expected to take one of two forms in the foreseeable future. First, the States Act which is before Congress seeks to get federal recognition that states have a right to make and implement their own marijuana laws without interference from the feds.

Alternatively, a statement by the Justice Department to the effect that the transfer of marijuana between states wouldn’t be a “priority for law enforcement” at the federal level can be interpreted to mean that states which have legalized marijuana can trade the substance between themselves.

Mike Getlin, a cannabis law reform advocate, says that should marijuana trade between states become a reality and Oregon isn’t poised to jump right in from the very onset, then a delay of even six months would be sufficient to knock the state out of contention as a major player in the interstate cannabis trade. Such an eventuality would flip the oversupply in Oregon from an asset to a major problem which can cripple the state’s cannabis industry.

SB 582 has provisions which would allow the Governor of Oregon to negotiate arrangements through which Oregon’s surplus marijuana can be sold to states where more supply is needed. The bill stipulates that only states where recreational marijuana is legal are eligible for an export and sale arrangement with Oregon.

Casey Houlihan, the head of the Oregon Cannabis Retailers Association, testified before the senate committee and revealed that the excess cannabis in Oregon will find its way to other states one way or the other, so it is better for mechanisms to be put in place so that the export can be done in a regulated way that brings revenue to state coffers.

Some of the cannabis companies that testified before the senate committee revealed that they had reduced their workforce by up to 80 percent because of the drop in marijuana prices due to oversupply within Oregon.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International, Inc. (NASDAQ: YGYI) look forward to a viable solution that can save the cannabis industry in Oregon from collapsing due to excess production.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

House Bill 364, a proposed law that seeks to allow patients taking medical cannabis to grow marijuana at home, has been approved by the senate in New Hampshire. The vote was close, but the bill sailed through 14-10.

Under the proposed legislation, patients who have been enrolled on the medical marijuana program of the state can have 12 medical marijuana seedlings, 3 young plants and 3 mature plants for their own use.

Currently, New Hampshire has 7,000 registered patients in the medical cannabis program. These patients have been compelled to get all their medical marijuana from just four Alternative Treatment Centers operating in the state.

The small number of retail outlets has resulted in high medical cannabis product prices, and many patients who cannot afford those products have resorted to using prescription opioids and other potentially harmful alternatives since medical marijuana isn’t covered by most insurance companies.

Activists have welcomed the bill saying that it will give patients a viable alternative to the expensive medical marijuana available at Alternative Treatment Centers.

There was resistance to the bill in the senate, and several changes were made in order to accommodate the concerns of the dissenting voices. For example, the bill initially had a provision which would allow a medical cannabis patient to gift marijuana to another patient who is registered to use medical cannabis in the state.

This provision was removed because there were concerns that such gifting would open the way to medical marijuana getting to the wrong people, such as criminal gangs selling marijuana on the black market.

Despite the changes, some senators, such as Sen. James Gray, are still adamant that legalizing home grows isn’t a good move. He said that the state has a rigorous system in place to make sure that the licensed cultivators only supply their products to the state-approved retailers. Allowing home grows creates a regulatory nightmare because it will be hard to monitor the plants grown by each patient who chooses to grow medical marijuana, Gray added.

Now that the bill has received senate approval, it now heads back to the House of Representatives where it had initially been approved and sent to the senate. The bill is coming back to the House so that the lawmakers there can consider the changes made by senate.

If the lawmakers in the House of Representatives pass the bill in its current form, then it will be sent to the desk of Gov. Sununu for a final decision on whether it becomes law.

TransCanna Holdings Inc. (CSE: TCAN) and Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) sympathize with the patients and call upon the authorities to pass the bill quickly so that those who cannot afford the medical cannabis in Alternative Treatment Centers can grow their own.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

A draft law through which Illinois will legalize recreational marijuana has been unveiled. The bill has some ambitious provisions, while others appear to have been borrowed from other states where marijuana is now legal for adult use.

One of the most noticeable provisions of the draft law is one that sets up a low-interest loan program worth $20million. Under this program, people from disadvantaged communities, such as African Americans, would borrow the money and set up cannabis businesses so that social equity can be promoted in the industry.

Another eye-catching provision in the law which was unveiled on Saturday (May 4) states that large-scale cultivators wouldn’t initially be licensed to operate within the state. Rather, small (“craft”) growers would be given priority at least for the first 12 months, and then larger players would be considered thereafter.

This emphasis on small growers is intended to spread the opportunities in the recreational cannabis sector to as many local players as possible.

The lawmakers also seem to have learnt a lot from California where local authorities have made it difficult for residents to access recreational cannabis by banning the operation of marijuana retail businesses in their jurisdictions. The draft bill in Illinois has a provision allowing local authorities to ban retail outlets within their areas for only the first 12 months.

Thereafter, any ban in a municipality can only be enforced once the voters in that jurisdiction approve the ban through a referendum. This is a great proposal because it puts the fate of recreational marijuana in municipalities in the hands of voters, rather than in the hands of a few municipal council members who may have divergent views from those of the people they represent.

The proposed law also has provisions on the likely taxes which will be levied on recreational marijuana products. For example, the lawmakers propose that customers will pay a 10 percent tax on cannabis products whose THC content is less than 35 percent while the products with a THC content that is higher than 35 percent will attract a 25 percent sales tax.

Entities that want to grow cannabis in the state will pay a permit fee of $100,000 while those who want to operate retail businesses will fork out $30,000 for a permit. Applicants from minority communities would pay lower permit fees so that the barriers to entry are reduced.

Debate on the bill is already heating up between proponents and those opposed to marijuana legalization. The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) hope that logic will prevail during these debates and the best law will be enacted for the people of Illinois.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

MjLink.com Inc., a wholly owned subsidiary of Social Life Networks Inc. (OTCQB: WDLF), this morning announced that CannabisNewsWire (“CNW”) will serve as the official newswire sponsor for its MjMicro Conference, which is billed as ‘The next level in cannabis investment’. The MjMicro Conference will take place at the Westin Grand Central in New York City on June 25, 2019.

“We are very pleased that CannabisNewsWire will be our official newswire and media sponsor,” MjLink President George Jage said in the news release. “The momentum of the cannabis movement has created huge opportunities for investors and public companies alike. CNW’s impressive ability to raise the visibility of the cannabis industry and its many players will provide an invaluable service to our conference goers, presenters and sponsors.”

To view the full press release, visit http://cnw.fm/1syVA

About MjLink.com Inc.

Social Life Network, a cloud-based social media and social network technology company based in Denver, Colorado, announced on September 25, 2018, the Company had spun its cannabis technology division out of the parent company and incorporated MjLink.com Inc., a Delaware Corporation, as its wholly owned subsidiary. MjLink operates as a multinational cannabis technology and media organization with two separate social networks: WeedLife.com, a consumer-to-consumer network and MjLink.com, a business-to-business social network. On April 4th of this year, the president of MjLink, George Jage, announced the launch of a new division of the company that is focused on providing the industry with best-in-class Financial, B2B and B2C cannabis centric events that complement their global social networks. For more information about Social Life Network and to download the MjLink Investor Deck, visit www.Social-Life-Network.com

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

On Wednesday (May 1), the Las Vegas City Council voted 4-1 in favor of a proposed ordinance that would see cannabis consumption lounges licensed to operate within the city. This means that the first consumption lounges could open by the end of this year.

Las Vegas becomes the first city in Nevada to pass regulations allowing cannabis consumption venues to open.

Carolyn Goodman, the mayor of Las Vegas, abstained from voting due to a possible conflict of interest. She had earlier revealed that one of her family members works in the cannabis industry.

According to the ordinance passed, cannabis retailers and dispensaries will be free to apply for a special use license which will allow them to open a cannabis lounge. Once the permit is granted, the licensed business can sell cannabis and allow the buyers to consume marijuana on the premises.

The consumption lounge permit will come with a number of conditions. First, such a lounge should not be located within 1,000 feet from a school or a casino. Additionally, each cannabis lounge must have a system to control smoke so that marijuana smoke doesn’t escape to the exterior of the consumption facility.

Another condition in the ordinance states that no one will be allowed to smoke cannabis outside the consumption lounge. Cannabis lounge operators are also barred from allowing alcohol within the consumption lounge.

The ordinance didn’t pass without some opposition. Casino operators were particularly concerned that licensing cannabis consumption lounges would increase the intoxication issues that casinos have to deal with since someone may use cannabis in a lounge and head to a casino where he or she can consume alcohol.

The restriction of the proximity of cannabis lounges to casinos may have been aimed at addressing the concerns raised by the casino owners, but only time will tell how effective that measure will be.

For now, only businesses with a license to dispense cannabis will be eligible to apply for a marijuana lounge permit. Other interested businesses will have to wait for at least 12 months before they can qualify for the permit.

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and SinglePoint Inc. (OTCQB: SING) applaud Las Vegas for taking the lead in allowing marijuana lounges in the state of Nevada. This step will solve a longstanding dilemma people have had because they could buy marijuana but didn’t have anywhere they could consume it outside their homes. The economy is therefore likely to benefit now that Las Vegas has decided to allow lounges to open.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

As more states move to legalize cannabis in the U.S., there is a tendency to think about marijuana in the same light as alcohol, and this sets up people to make a number of mistakes. Below are three things that you are likely to get wrong when you look at cannabis through the same lens as you think about alcohol.

Expecting Quick Results from Consuming Marijuana Edibles

When you take alcohol, it is fairly easy to know when you are approaching your limit and are now crossing into the realm of intoxication.

When some people consume cannabis edibles for the first time, they make the mistake of thinking that the products will produce immediate effects in a way that is similar to the timeline within which alcohol produces its effects.

What you may not know is that while alcohol can be absorbed by the stomach lining, cannabis edibles have to be digested and absorbed in the small intestine before you can notice the effects of the edible.

Consequently, it is possible to consume more than is needed to generate the effects that you want just because what you ate took long to kick in.

Expecting THC Concentration to Match Intoxication Levels

For decades, scientific data has existed showing that when someone’s blood alcohol level exceeds a certain concentration, then that person will be impaired. For this reason, courts have always upheld the charges against those found to be driving while under the influence of alcohol.

Many law enforcement agencies are taking the same view when determining driving while under the influence of marijuana. What these agencies don’t seem to appreciate is the fact that marijuana acts differently from alcohol.

It is therefore not possible for one to claim that someone was under the influence just because their blood had more THC than is stipulated as the legal limit.

Prosecutors are therefore likely to face a hard time from defense attorneys who bring into question the science behind the THC limits upon which intoxication is presumed.

Expecting Marijuana to Have the Same Effect

The effects of alcohol are fairly uniform across the different types. For example, someone who takes a certain number of glasses of wine is expected to be affected in a certain way. Similarly, one can predict how a given number of pints of beer will affect an individual.

However, the same cannot be said of cannabis due to the varying combinations and concentration of the components available in a given plant or strain. For example, the terpenes that give cannabis strains their flavor and taste can influence the effect of consuming that cannabis.

It is therefore erroneous to make generalizations about the effects of cannabis because it is hard to predict how the different cannabis products will react once consumed.

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Net Element Inc. (NASDAQ: NETE) call for cannabis to be studied thoroughly so that the plant isn’t judged based on misconceptions borrowed from what is known about other substances.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Related Editorial
Projections for the cannabis markets are staggering, yet there’s evidence that the lofty estimates may be understated.

• Cannabis projections often fall far short of actual sales growth.
• Cannabis-infused beverages looks to be next area of explosive upside.
• Beverage and cannabis companies striking deals to gain market access.
• New technologies could snag significant market share.

Once viewed as wild conjecture for the future of cannabis markets, forecasts in 2015 fell severely short of actuality. At that time, consensus was that Canada could reach CA$2.8 billion in legal sales by 2020. Sage prognosticators now say that the market may exceed CA$7 billion in 2019. Catering to the tastes of market demographics, intense interest is now focused on the cannabis-infused beverages market. Not even legal in Canada until this fall, the infused beverage market is already pegged to reach a mind-boggling CA$4.4 billion within five years.

Joining the ranks of the majors to meet this titanic demand, Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (SRUTF Profile) announced a joint venture with Moosehead Breweries, the largest and oldest independent beer company in Canada. Cannabis colossus Tilray Inc. (NASDAQ: TLRY) announced a research partnership into infused beverages and is bringing in executives with backgrounds in the beverage industry. The maker of Corona and Modelo beer increased its stake in Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) to 38%, spurring speculation of cannabis-infused beverages to come. HEXO Corp. (NYSE American: HEXO) (TSX: HEXO) entered a joint venture with Molson Coors Canada to produce CBD-infused beverages. And New Age Beverages Corp. (NASDAQ: NBEV) is anticipated to begin roll out of Marley+CBD-infused drinks in four targeted U.S. states.

To view the full editorial, visit http://cnw.fm/vSRx2

To hear the CannabisNewsAudio version, visit http://cnw.fm/y9shU

About Sproutly Canada Inc.

Sproutly Canada’s core mission is to become the leading supplier to the cannabis beverage and edibles market. The company’s Toronto-based, ACMPR-licensed facility was built to cultivate pharmaceutical-grade cannabis to supply a technological breakthrough in producing and formulating the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bionatural oils will deliver revolutionary brands to international markets that are clamoring for well-defined commercial products. Sproutly’s business focus is to execute on partnerships with local and globally established consumer brands to leverage its existing customer bases, further expand brand loyalty, assist with marketing and support distribution networks to deliver this scientific breakthrough with speed and efficiency worldwide. For more information, visit the company’s website at www.Sproutly.ca.

NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company’s newsroom at http://cnw.fm/SRUTF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

Moosehead Breweries Ltd, one of the largest breweries in Canada, has announced that it plans to form a joint venture with Sproutly Canada, Inc. in order to make cannabis-infused drinks. The drinks will be introduced on the Canadian market by the end of this year.

Andrew Oland, the CEO of Moosehead Breweries Ltd, said that the company wants to enter the cannabis beverages space as soon as the federal government in Canada releases rules to regulate cannabis edibles in the country.

As a leader in the beer industry, Moosehead is convinced that the company is well placed to be a major player in the cannabis drinks sector.

Once the joint venture is finalized, Mathew Oland will be its head. Mathew Oland is a former Vice President of Moosehead Breweries and in that role, he superintended the supply chain infrastructure of the brewery. While at the joint venture, Mathew Oland will oversee Research and Development (R&D), procurement and distribution as well as the operations of the new entity. A name for the joint venture hasn’t yet been agreed upon. The financial aspects of the joint venture are also yet to be finalized.

Keith Dolo, the CEO of Sproutly Canada, revealed that the joint venture will be given exclusive rights to use Sproutly Canada’s technology for five years, which can be extended for two more years.

Dolo added that working with Moosehead will expedite the process of getting the drinks developed to the market in a sector that is expected to be highly competitive.

To get an idea about how tough the competition is likely to get, consider the fact that Canopy Growth and Constellation Brands are finalizing a bottling line for cannabis beverages. Another cannabis company, Hexo Corp. also teamed up with Molson Coors Brewing Company to make marijuana-infused drinks. Other small players have also expressed their interest in entering the cannabis drinks market.

However, the drinks made using Sproutly Canada’s technology may have an edge in the industry since this technology shortens the time within which a person can feel the effect of the drink he or she has consumed.

Just for comparison purposes, the cannabis drinks available in California take more than an hour to kick in and the effects wear off between 4-8 hours later. In contrast, Sproutly’s technology results in a cannabis drink whose effects are felt within five minutes and those effects wear off in less than two hours. No prizes for guessing which product stands a higher chance of being a hit in the market!

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) and Sugarmade Inc. (OTCQB: SGMD) congratulate Sproutly Canada, Inc. and Moosehead Breweries Ltd upon their desire to form a joint venture so that Canadians can have an increased number of options to select from when they want a cannabis beverage.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Confident Cannabis, a cannabis wholesale platform, has raised $12m to bring its total capitalization to more than $18m from their inception. The new funding is intended to enable the company to expand its operations into new territories across the country.

The Series A funding round was led by Poseidon Asset Management, a cannabis venture capital fund based in San Francisco. Other entities that invested more funds in Confident Cannabis include Y Combinator, Bullpen Capital, FJLabs as well as Greenfield Global and Base Ventures.

Confident Cannabis focuses on empowering all verticals within the cannabis industry so that all players, including cultivators and finally customers of cannabis end-products can know what is available in the industry, who makes it and what that specific product is made from. Confident Cannabis’ platform makes all this information available in real time, and the data they provide is verified by independent labs.

Last year in October, Confident Cannabis launched its platform, Wholesale, in Oregon. This meant that, for the first time, all players in the cannabis industry could interact with each other without having any fears about the authenticity or quality of the products showcased on the platform. The doubts were removed because Wholesale availed lab test results from licensed testing facilities.

Morgan Paxhia and Emily Paxhia, the two cofounders of Poseidon Asset Management, revealed that they decided to invest in Confident Cannabis after watching it closely from 2015 and seeing how far Confident Cannabis has come.

Emily Paxhia added that they were intrigued when all labs they encountered raved about how good the software provided by Confident Cannabis was. This was unexpected, because testing facilities rarely sing the praises of the software powering their systems. Poseidon Asset Management was hooked, and their participation in the Series A funding round is testament to their confidence in the future of Confident Cannabis.

Currently, more than 40 percent of all the marijuana which is produced legally within the U.S. passes through the lab testing platform run by Confident Cannabis. The expansion of their operations into more markets will avail that inventory of cannabis to more wholesalers, retailers and consumers.

All the entities that participated in this funding round praised Confident Cannabis for helping to increase compliance within the marijuana industry by providing solutions which address the current and future needs of the industry.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) wish Confident Cannabis all the best because what they are doing helps all other players in the industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]

Charles R. Broderick, a cannabis investor, has donated $9 million to his alma mater (Harvard and Massachusetts Institute of Technology-MIT) so that the two institutions can conduct research into the health effects of cannabis.

The two academic institutions described the donation that they had received as the largest ever private funding into marijuana research.

Speaking about his donation, Broderick said that the absence of sufficient scientific research on cannabis has allowed some players in the industry to make claims that may be hard to verify. He added that since prohibitionist laws are collapsing around the world, the time has come to study the plant so that people have accurate information rather than having to rely on old science or anecdotal evidence.

One of the areas that will be focused on during the research funded by Broderick is the psychological and cognitive effects of marijuana.

Charles R. Broderick has been investing in the cannabis industry since 2015. He got his feet wet in Canada and then later expanded his interests into the U.S. marijuana industry.

The investor reveals that Harvard was initially reluctant to accept his donation due to Broderick’s involvement in the cannabis industry. However, his offer was accepted after brain chemical researchers at the university were excited by the opportunity.

MIT and Harvard insist that the findings of the research will not be influenced in any way by the interests of the donor. The institutions vowed that they would release their findings to the public regardless of whether the findings indicate that marijuana is harmful or helpful.

Meanwhile, interest in cannabis research is growing in academic circles. Additionally, the boom in marijuana industry jobs has prompted many universities to start offering some form of cannabis courses.

For example, Colorado State University offers students a minor in the legal, social, health and political impact of cannabis. Harvard, Ohio State University and the University of Denver all offer courses on marijuana law and policy.

The jobs that students expect to get after taking those cannabis courses vary in accordance with the range of products and services created by the cannabis industry. These include the medical uses of cannabis, the manufacture of fabrics from hemp, the processing of cannabis-infused foods and beverages, making of recreational cannabis products, etc.

Currently, recreational marijuana is legal in 10 states and more are queuing to join that list. Medical cannabis is permitted in 33 states across the U.S. For this reason, MustGrow Biologics Corp. and Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) welcome the donation made by Broderick since the research done will make more information available about cannabis so that the excuse of insufficient research used by detractors will be no more.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
[email protected]